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Endothelial cells are exposed to oscillatory shear stress at sites prone to 
atherosclerotic and aneurysmal formation.  These cells sense low or oscillatory shear 
stress and signal the blood vessel wall to remodel to maintain an open lumen for the 
passage of blood.  Remodeling involves protease degradation and reconstruction of the 
extracellular matrix structural components.  Several different proteases are capable of 
degrading these elastin and collagen components including matrix metalloproteases and 
lysosomal cysteine proteases (commonly called cathepsins).  Although they were first 
identified in the lysosomes, these proteins are secreted by certain cells and are potent 
elastases and collagenases.  To regulate their extracellular proteolytic activity, cystatin C, 
their most powerful inhibitor, exists in relatively high concentrations to reversibly bind 
and inhibit them.  Once cystatin C is downregulated, however, the cathepsins can now 
degrade and remodel the structural components of the blood vessel wall to advance 
atherosclerotic plaque development. This downregulation of cystatin C by an endothelial 
cell mediated pathway is a key point in plaque development and must be addressed and 
understood instead of solely implicating matrix metalloproteases in this disease process; 
new therapeutic targets can then be designed. 
The novel and significant finding of this study is that exposure to atheroprotective 
unidirectional laminar shear stress (LS) decreases elastase and gelatinase activities of 
endothelial cells through a shear stress mediated reduction in cathepsin activity.  
Oscillatory shear stress increases this activity.  Cathepsins K, L, and S, elastinolytic and 
collagenolytic proteases, are shown to be regulated by shear stress in these studies at the 
level of the protein and activity.  Cathepsin B was not responsive to shear stress.  The 
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endogenous inhibitor of the cathepsin family, cystatin C, was found to be inversely 
regulated by shear stress; LS increased its secretion by endothelial cells while OS 
decreased it.  Binding of free cystatin C in the conditioned media to carboxymethylated 
papain coated agarose beads led to an increase in cathepsin activity since the available 
cathepsin was not inhibited.  Additional roles for cathepsins K, L, and S were found in 
endothelial cell alignment in response to unidirectional laminar shear stress, endothelial 
cell migration, and programmed cell death.  
Immunolabeling of cathepsins K, L, and S in mouse aortic endothelial cells after 
exposure to OS, LS, or St conditions verify that cathepsins L and S are predominantly 
lysosomal in location intracellularly even though they are secreted by the cells as well.  
Cathepsin K staining suggests that it is not only intracellularly, but also bound on the cell 
membrane as detected in plasma membrane fractions of the endothelial cells and 
visualized with subcellular proteome extraction followed by immunostaining. 
To verify these findings in human samples, immunohistochemical analysis of 
cystatin C and cathepsin K was performed on human coronary arteries.  Cathepsin K 
stained strongly in the endothelial layer of vessels with degraded internal elastic lamina 
while cystatin C staining intensity was strongest overlying minimally diseased vessels.  
This again corroborates the inverse regulation of cathepsin K and cystatin C in 
endothelial cells of large arteries and identifies the cathepsin family of proteases as 
potential targets for therapeutic intervention of atherosclerotic plaque development at 






Cardiovascular disease and shear stress studies have been linked for the last two 
decades.  Endothelial cells line the blood vessel wall and serve several functions; they 
inhibit platelet aggregation and coagulation, selectively transport macromolecules from 
the blood into the blood vessel wall, and most importantly for this study, sense 
hemodynamic flow.  It has been well established that differences in local hemodynamics 
induce different cell signaling pathways in endothelial cells (1-6).  A unidirectional 
laminar shear stress signals the endothelial cells to produce nitric oxide, a vasodilator, 
and other atheroprotective agents (7).  Oscillatory shear stress induces apoptotic signals 
and cell adhesion molecule expression to encourage monocyte adhesion leading to an 
inflammatory response and atherosclerosis.  One such protein induced by oscillatory 
shear stress is BMP-4 which upregulates ICAM-1 leading to monocyte adhesion (8).  
This review will focus on the shear stress mediated cardiovascular pathologies such as 
atherosclerosis, abdominal aortic aneurysms (AAA), and valvular diseases and the 
proteases responsible for the pathological remodeling that occurs during their 
development. 
Shear stress 
 Shear stress can be defined as a tangential force over a surface area, and in the 
vasculature, this corresponds to the dragging force of blood as it flows over the blood 
vessel wall, the valve leaflets, or the cardiac wall.  The viscosity of the blood and the 
velocity gradient are proportional to the shear stress at the wall:   
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τ = µ du/dr 
 
 and can be described by  
 
τwall = 32µQ 
          πD3 
 
for steady laminar flow in a straight tube (9). 
 
In vitro determination of flow profiles in different cardiovascular geometries and 
anatomical locations have mostly been carried out in the lab with their recreation in glass 
tube models.  Particle tracking velocimetry, hydrogen bubbles, and other methods (as 
reviewed by Ku (9) provide a visual picture of the three-dimensional flow while laser 
Doppler anemometry, pulsed Doppler ultrasound, and Hot-film anemometry were used to 
determine the velocity profiles (10-13). 
Clinical determination of wall shear stress used calculations from velocity 
measurements detected using Doppler ultrasound and magnetic resonance imaging (MRI) 
(14, 15).  These tools can be combined with computational fluid dynamics (16, 17) to 
mathematically predict the velocity and shear stress profiles at distinct locations and 
defined geometries.  It is important to note calculations of wall shear stress by these 
methods still contain a degree of error. 
 
Shear stress and cardiovascular diseases 
The importance of shear stress in vascular biology and pathophysiology has been 
highlighted by the focal development patterns of atherosclerosis in hemodynamically 
defined regions. For example, the regions of branched and curved arteries exposed to 
disturbed flow conditions including oscillatory and low mean shear stresses (OS) 
3 
correspond to athero-prone areas.  In contrast, straight arteries exposed to pulsatory, high 
levels of laminar shear stress (LS) are relatively well protected from atherosclerotic 
plaque development (18).   
Several human and animal studies have also demonstrated that atherosclerotic 
lesions and abdominal aortic aneurysms (AAA) occur in regions exposed to unstable flow 
conditions including flow reversal, low mean wall shear stress and high oscillatory shear 
index (16, 19-23).  Diminished flow has also been shown to cause AAA in patients with 
above the knee amputations making them five times more prone to this disease (24), and 
patients with peripheral vascular disease also have reduced flow and increased risk of 
developing AAA (25).  In contrast, relatively high levels of laminar shear stress were 
shown to reduce AAA progression in rat experimental models (26). 
 Aortic valves and mitral valves function in complex hemodynamic environments 
due to the opening and closing of the valves. Different sides of the valve leaflets each 
experience a different flow environment (27), and this alters the endothelial behavior on 
the valve leaflets (28).  In valves, the fibrosa layer which is on the aortic side of the aortic 
valve is exposed to disturbed flow and prone to development of calcification and valvular 
atherosclerosis, believed to develop due to the hemodynamics to which they are exposed 
(28).  Their preferential development on the aortic side suggests that hemodynamic 
contribution is important in their valvular formation as well. 
The common factor in each of these cardiovascular diseases is that endothelial 
cells line these structures and are the fluid shear stress mechanosensor.  Endothelial cell 
response to shear stress has been studied from the transcriptional level all the way up to 
proliferation and migration.  Overwhelming evidence indicates that high levels of 
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unidirectional laminar shear stress increases nitric oxide production causing vasodilation 
and arterial health (1, 6).  Pro-inflammatory cytokines, such as BMP-4 (8, 29), and cell 
adhesion molecules, such as VCAM-1, are turned down under LS to retard the initial 
inflammatory responses that lead to atherosclerotic plaque formation.  More importantly 
for this study, high levels of unidirectional laminar shear stress inhibit the vascular 
remodeling that is found in regions exposed to disturbed or stagnant flow.  At sites of 
disturbed flow, intimal thickening and breakdown of the elastic laminae structures are 





Atherosclerotic plaque formation requires major remodeling of the blood vessel 
wall.  Monocytes enter the blood vessel wall using the cell adhesion molecules expressed 
by the endothelium under oscillatory shear stress and in response to oxidized LDLs.  
They differentiate into macrophages and begin to phagocytose lipids in the wall, 
transform into foam cells, and eventually rupture and release their contents back into the 
subintimal space (30).  Cytokines such as IL-1β and IFN-γ released from the 
macrophages and foam cells reach the smooth muscle cells in the medial layer of the 
blood vessel wall and signal them to change phenotype.  Usually, the smooth muscle cells 
in this layer are of a contractile phenotype, serving to maintain tension in the artery (31), 
but they change to a migrating, secretory phenotype.  As the macrophages secrete 
superoxides and proteolytic enzymes, they create an acidic milieu to activate proteolytic 
enzymes (32), which can degrade the elastic layer separating the smooth muscle cells 
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from the endothelial cells.  Those smooth muscle cells that have converted to the 
secretory phenotype are now capable of migrating through the fragmented elastic laminar 
layer into the intimal region of the blood vessel wall where the atherosclerotic plaque is 
forming.  Positive feedback continues as they also rupture once they have internalized too 
many lipids releasing all of their contents as well into the advancing plaque region. 
 
Abdominal aortic aneurysms 
 
Aneurysms are defined as a permanent dilatation of a blood vessel, and one that 
occurs in the infrarenal aorta is termed an abdominal aortic aneurysm.  Elastin and 
collagen destruction in this section of the aorta are characteristic of AAA. Fragmentation 
of the elastic fibers in the medial layer is an initial step in AAA development, but loss of 
the structural support of types I and III collagen in the adventitia as they are degraded 
eventually causes rupture of the aneurysm, from which 65% of patients die (33). 
The abdominal aorta is subject to disturbed flows because of anatomical factors 
such as the diaphragm, the lumbar curvature, and low resistance in the renal arteries.  
These cause the formation of strong vortices, skewed flow, and reverse flow into the 
renals, respectively (9) all leading to oscillatory and low average wall shear stress.  Glass 
tube models of the abdominal aorta were used to visualize these flow changes, and they 







The aortic valve experiences a complex hemodynamic environment. Three 
distinct flow regions exist in the aortic valve: the aortic wall of the sinus of valsalva 
characterized with low, disturbed flow; the side of the leaflets facing the aorta with low 
shear, laminar flow and the side facing the ventricle with high shear, laminar flow (36).  
Myxomatous heart valve disease is characterized by collagen fragmentation and 
accumulation of proteoglycans and eventually leads to prolapse of the leaflets (37); it 
generally occurs focally in the mitral valve suggesting a role for hemodynamics in its 
development, and proteases have been identified as being upregulated in myxomatous 
heart valve leaflets (38).   Senile valve disease occurs preferentially on the aortic side as 
well and is characterized by fibro-calcific formations, inflammation, and 
neovascularization in its later stages (37); all of these have been linked to disturbed flow 





In vitro shear stress systems. 
 
 The two most widely used devices to actuate shear stress on endothelial cells in 
vitro are the cone and plate viscometer and the parallel plate flow chamber.  For the cone 
and plate apparatus, endothelial cells are cultured to confluence on a tissue culture dish 
prior to placing a cone into the medium and rotating it at the appropriate speed to obtain 
arterial levels of shear stress on the adhered endothelial cells with cone angle and media 
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viscosity considered in the design of the cone (39-41).  Magnetic stir bars or 
programmable motors are used to control the speeds of rotation.  Engineering analysis of 
these systems yielded equations that can be used to calculate the shear stress at the 
endothelial cell surface and the limits to which the cone and plate can actuate 
physiological, laminar shear stress profiles (2, 39, 41).  This is the preferred method of 
exposing endothelial cells to shear stress in our lab and will be used for the studies in this 
manuscript.  Cone and plate shear apparatus have  been used in studies of cell adhesion 
molecules (42, 43) , secreted protein and activity (44, 45), and shear stress induced 
signaling cascades (46-49). 
 
Figure 1.1 Schematic of cone and plate shear apparatus.  Ř is a non-dimensional 
parameter, analogous to the Reynolds number, indicating laminar azimuthal flow for 
values of Ř < 1 (r=radius of cone, ω=angular velocity, α=cone angle, ν=kinematic 
viscosity).  Within these parameters the plate shear stress. τw, is uniform across the plate 
and equal to µω/α (µ=viscosity, ω=angular velocity, α=cone angle) (2).   
 
 Parallel plate flow chambers are governed by a different set of equations and 
assumptions.  Endothelial cells are cultured on glass slides and placed in a sterile 
chamber, and media is pumped across the cells to actuate the shear stress.  Pressure 
difference and height above the glass slide determine the level of shear stress experienced 
by the cells (50).  Cell proliferation, calcium flux, viscoelastic properties, intracellular 
100mm culture plateEndothelial cells
R ≡ r2ωα2 ~ 
12 υ 
µω 






signaling, and other concepts have been studied with these flow chambers (51-58).  They 
have also been used to study valve leaflet responses to shear stress (59). 
 
Ex vivo models 
 
 Organ culture systems offer added advantages over cell systems because the 
interaction of the different cells that comprise the blood vessel or the valve leaflet can be 
observed while recapitulating the three-dimensional flow environment such as was done 
in the original glass casts used for hemodynamic investigations.  Porcine (60, 61), mouse 
(62), and human (63)  ex vivo systems have been described to culture entire arteries for 
extended periods of time.  Gambillara et al have cultured left common porcine carotid 
segments in a perfusion system and even studied oscillatory shear effects (64, 65). 
Alternatively, groups are using co-culture models of smooth muscle cells with endothelial 
cells as a method to study cell interactions.  Some of these models seek to recreate the 
three-dimensional architecture while others focus on the cytokines and crosstalk between 
the cells (66, 67).  Heart valve ex vivo studies have been valuable model systems as well 
supplying information on matrix remodeling due to pressure and shear stress (68-70). 
In vivo models 
 
Flow cessation models 
 Ligation of the carotid artery is used in vivo to block flow and examine the 
responsive vascular remodeling.  In mice, sufficient blood flow still reaches the brain 
through other vessels so that the ligation is not fatal. This model of flow cessation causes 
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induction of proteases, intimal hyperplasia, macrophage infiltration, all with an intact 
endothelium (71-74). 
Low flow  
Low flow models in vivo have been accomplished with partial ligations of carotid 
arteries (75) or by ligation of internal carotid artery and of the three of the other branches 
of the external carotid artery (76).  Partial outflow occlusion models also lead to lower 
flow through the artery of interest (77).  Intimal hyperplasia and protease induction are 
seen in these animal models as well.  Humans with peripheral vascular disease experience 
low flow in the abdominal aorta, and it also subjects them to a greater risk of developing 
abdominal aneurysms (25). 
High flow 
Arteriovenous fistula (AVF) operations are prevalent animal surgeries performed 
to generate high flows in vivo.  Usually, the fistula is created between the carotid artery 
and the jugular vein.  This procedure is more often performed in rabbits (77, 78), but has 
also been created in Sprague Dawley rats (79) and mice leading to an increase of shear 
stress from 35 to 261 dynes/cm2 in right common carotid artery AVF (80).  Combination 
studies have been performed with partial ligation of the left carotid artery after ligations 
of the internal and left external carotids.  This decreased flow in the left carotid artery by 
90% but caused an increase in flow in the right carotid artery (75).  Effects of both low 




Oscillatory flow  
Besides the natural geometry of the vascular tree that induce oscillatory flow such 
as the carotid bifurcations, lesser curvature of the aorta, and the sharp turns of the 
coronary arteries, Shu Chien’s group has developed a U shaped titanium clip that can be 
placed on the rat aorta to induce oscillatory flow and unidirectional flow in vivo at 
straight sections of the aorta (81).   
Proteases and Remodeling 
 
Matrix metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases 
(TIMPs) 
MMPs are the class of zinc and calcium dependent endopeptidases that have been 
highly investigated in vascular biology and matrix remodeling.  Currently, 14 MMPs 
have been studied in vascular cells.  They are synthesized as zymogens, with a propeptide 
that must be cleaved to activate the latent enzyme.  MMPs and members of other protease 
families are capable of this cleavage putting into motion a cascade of proteolytic activity 
to increase their combined activity.  Together, as a family, MMPs are capable of 
degrading all of the components of the vascular extracellular matrix and are classified 
according to their substrate preference: collagenases, gelatinases, stromelysins, 
membrane-type MMPs, and others (82).   
TIMPs are the endogenous, potent inhibitors of MMPs and are also studied in 
vascular physiology to observe any shift in the balance from inhibition to proteolysis by 
this family.  There is a 1:1 stoichiometric binding of TIMP to MMP that involves the N-
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terminal cysteine displacement of the water molecule at the active site from the zinc ion 
(83). 
Endothelial cells, smooth muscle cells, and macrophages all secrete MMPs (84)  
in the vascular wall in response to different stimuli as reviewed by Newby including 
mechanical injury, mechanical forces such as shear stress and stretch; inflammatory 
cytokines interleukin-1 and tumor necrosis factor-α; and growth factors platelet-derived 
growth factor and fibroblast growth factor-2 (82).  Many of these factors induce vascular 
remodeling which can be healthy or pathological (84).  Atherosclerotic remodeling leads 
to breakdown of the elastin and collagen components of the vascular wall and change in 
SMC phenotype from contractile to secretory and migratory; MMP involvement has been 
shown with knockout mice backcrossed to ApoE knockout mice fed a high fat diet.  
MMP-9 and ApoE double knockout mice showed reduced plaque burden and 
atherosclerosis compared to ApoE knockout mice controls (85). The elastic lamina was 
also more intact with the genetic absence of MMP-9 or MMP-12 (85).  Conversely, 
genetic null TIMP-1 mice had increased aneurysmal formation but reduced 
atherosclerotic plaques when crossed with ApoE knockout mice and fed a high fat diet 
(86) showing the importance of these matrix proteases in pathological vascular 
remodeling and how their inhibition contributes to vascular stability. 
Hemodynamic regulation of MMPs has also been described using the above listed 
shear stress systems.  In vitro studies of a murine endothelial cell line showed that 
laminar shear stress upregulated MMP-2 and MMP-9, oscillatory flow increased MMP-9 
(87).  Shear stress did not increase MMP-2 and MMP-9 activity in an ex vivo porcine 
artery culture, but transmural pressure did induce their activity (60).  Flow cessation 
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models heavily implicate induction of MMP expression and activity in vascular smooth 
muscle cells as a mechanism for intimal hyperplasia (71-73, 88).  Low flow induced 
intimal hyperplasia upregulates MMP-9 (75, 76), but high flow also increases MMP-2 
and -9 activity and degradation of the internal elastic lamina in a rabbit model of AVF 
(89). With balloon injured right common carotid arteries in rabbits, MMP-2 activity 
increased by 186% left in normal flow; partial outflow occlusion after injury to maintain 
low flow increased its activity by 366% while high flow brought on by ligation of the left 
common carotid caused only a 39% increase (77).  
MMPs are also involved in remodeling of heart valves under disease conditions.  
Myxomatous heart valves are floppy heart valves due to the degradation of elastin and 
collagen components and MMP-1, -2, -9, and -13 have been identified 
immunohistochemically (38), and MMP-1 and -2 have been identified in healthy human 
heart valve leaflets (90).  Bicuspid aortic valves have impaired hemodynamics and lead to 
failure, remodeling, and disease; MMP-2 and -9 were increased in  human bicuspid aortic 
valves compared to human triscuspid aortic valves (91).   
 
Cathepsins and cystatins 
The cathepsin family of cysteine proteases has been studied far less than MMPs in 
vascular remodeling and literature is particularly sparse in flow mediated cathepsin 
dependent vascular remodeling.   
Cysteine proteases are involved in the catalysis of other proteins using their 
respective OH- and SH- groups at the active site to cleave amide bonds.  The two main 
families of cysteine proteases are the caspases and the papain superfamily.  Caspases are 
well known to be involved in apoptotic cell death pathways, and the papain superfamily 
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(comprising the cathepsins) are mainly found in lysosomal compartments, but have been 
shown to be secreted by macrophages and osteoclasts.  “Cathepsin” is the main term used 
for this superfamily of cysteine proteases, and their activity is highly regulated.  
Cathepsins function best in an acidic pH, and they are only weakly active at a neutral pH.   
They prefer a reducing environment and are synthesized as an inactive precursor, 
requiring proteolytic cleavage of a propeptide region.  In addition, there are several 
inhibitors constantly present in high ratios to the cathepsins (32, 92-95). Ultimately, 
expression of a cathepsin does not mean it will play a physiological role; it must be 
moved to an acidic environment, activated, and be free from inhibition.  When the 
regulatory mechanisms fail, cathepsins are capable of causing pathological damage. 
Emphysema (92), Alzheimer’s disease (96), pycnodystosis (97), tumor metastasis (92, 
98) rheumatoid arthritis (99), muscular dystrophy (92), and now atherosclerosis, the 
subject of this study, show cysteine protease involvement (92).  
Cathepsin S is a potent elastase and has the special characteristic that at neutral 
pH, it is still active, making it unique among the papain family of cysteine proteases 
(100).  Shi et al. found it in atherosclerotic plaques (101).  There was decreased elastic 
lamina breakdown and reduced plaque development in Cathepsin S and LDL receptor 
double knockout mice (102).  There was also decreased microvessel growth without 
cathepsin S.  Macrophages have been identified as one of the cell types that secrete this 
cysteine protease pericellularly (31).  It has already been linked to emphysema (92), the 
destruction of the alveoli, and is now being investigated for its role in atherosclerosis. 
Cathepsin L is as potent an elastase as cathepsin S, but it only functions in acidic 
pH (103).  It is also secreted by macrophages at sites of inflammation (31).  Although 
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secreted in the proform, it can be activated in the acidic, local environment created by the 
macrophages.  Active cathepsin L in aortic aneurysms further implicates this cysteine 
protease in cardiovascular disease (104).  Disease pathologies include tumor metastasis, 
bone resorption, as well as implications in arthritis (92). 
Cathepsin B is one of the more abundant cathepsins with lysosomal 
concentrations as high as one millimolar (94).  Much work has been done on the 
collagenolytic abilities of cathepsin B and its role in tumor metastasis by degrading the 
basement membrane of tumor cells (105).  Once again, pathologies develop from 
cathepsins being placed outside of the lysosomes; cathepsin B can be relocated to the 
tumor cell surface and bound to annexin II where it is activated (106).  Additionally in 
vivo atherosclerotic imaging has identified the presence of cathepsin B (107). 
Cathepsin K is a potent (94, 108, 109) collagenase and elastase that we have 
found is secreted into the conditioned media by MAECs.  It is the most potent 
collagenase, capable of cleaving mature type I collagen in the native triple helix and in 
the telopeptide regions (110) while other collagenases can only cleave at one or the other.  
Although this protease was first characterized regarding osteoclast bone resorption, it has 
also been located in atherosclerotic plaques (101).  ApoE null mice that were also null for 
Cathepsin K had smaller plaques, increased collagen content, and less elastic lamina 
breaks (111). 
Cathepsins B, K, L, and S are elastinolytic and collagenolytic, proving capable of 
degrading the main structural components of the blood vessel wall (32, 104, 107, 112).  
The acidic environment created by macrophage secretions in the plaque-forming, intimal 
region would provide an adequate environment for cathepsin activity.  Atherosclerotic 
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lesions, now being classified as sites of inflammation, are shown to be acidic (113).  
Macrophages acidify the local environment through a vacuolar type ATPase pump that is 
also activated by close contact with elastin, creating acidic microenvironments optimal 
for cysteine protease function (114).  Release of these proteases into the intimal region of 
the vessel wall by endothelial cells demands that an inhibitor be present to keep their 
activity at a minimum and to avoid a pathological condition.  Cystatin C is just such an 
inhibitor. 
Cystatins are the group of inhibitors of lysosomal cysteine proteases, of which, 
cystatin C is the most powerful (100).  This 13 kD protein is translated with a 26 amino 
acid signal peptide that targets it for secretion approximately one hour after post-
translational processing (116).  At this point its three-dimensional conformation forms a 
wedge shape that will block the substrate binding cleft of the cathepsin in a tight, 
reversible fashion(117) with an inhibition constant on the subnanomolar range (118).  In 
the context of atherosclerosis, its production and secretion has been studied in smooth 
muscle cells of blood vessel walls.  TGF-β, a cytokine present in blood vessel walls, 
induces an increased secretion of cystatin C from smooth muscle cells although there is 
no detectable change in its mRNA levels (112).  Cystatin C has also been found in 
normal blood vessel tissue sections in the medial layer, but was absent in atherosclerotic 
sections (101, 112).  Its production by endothelial cells remains elusive.  We have found 
that cystatin C is upregulated by endothelial cells in response to laminar shear stress 




Table 1.1.  DNA microarray data from mouse aortic endothelial cells exposed to 24 
hours of unidirectional laminar shear, oscillatory shear stress, or static, no flow 






Unidirectional laminar shear stress inhibits cathepsin levels and maintains high 
levels of cystatin C in the blood vessel wall through an endothelial cell mediated 
pathway, but oscillatory shear stress leads to a pro-atherogenic environment with greater 
cathepsin activity and decreased cystatin C.  Here, this project offers the novel idea that 
the upregulation of cathepsins and inverse downregulation of the cathepsin endogenous 
inhibitor, cystatin C, is a key point in blood vessel wall remodeling, atherosclerotic 




   Fold Change
Oscillatory Shear 
    Fold Change
      
CYSTATIN C  2.45 0.92 
CATHEPSIN L   2.46 1.94 
CATHEPSIN B    0.85 1.05 
CATHEPSIN K           1.04 2.62 







Figure 1.2: Schematic of overall hypothesis.  Without the inhibition of cystatin C due 
to upregulation by unidirectional laminar shear stress, cysteine proteases can degrade 




Specific Aim 1:  Understand endothelial secretion and activation of cathepsins due to 
oscillatory shear stress and their contribution to extracellular matrix proteolysis. 
Hypothesis: Oscillatory shear stress signals endothelial cells to secrete cathepsins, 
perhaps initially to maintain an open lumen and return shear stress level to normal.  
However, they become pathological once they persist and are uninhibited by cystatin C. 
 
Specific Aim 2: Determine the atheroprotective, molecular role of cystatin C in the 
cardiovascular system in response to unidirectional laminar shear stress.   





 Endothelial cell 
Oscillatory shear stress
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Hypothesis: Cystatin C is a mechanosensitive protein that serves to inhibit cathepsins 
from degrading the internal elastic lamina and remodeling the blood vessel wall in a 
unidirectional, laminar shear environment to retard atherosclerotic plaque development.   
 
Specific Aim 3:  Examine the alternative roles for cathepsins and cystatin C in 
endothelial cell physiology. 
Hypothesis:  Oscillatory shear stress turns on signaling pathways that lead to cathepsin 
transcription, expression, or activation in endothelial cells that may have other cellular 
functions besides protein turnover in lysosomes. It is important to understand these 
additional roles so that therapeutic interventions do not lead to other malfunctions in the 
cells.   
 
The goal is to further understand how shear stress regulates proteolytic mechanisms in 
the blood vessel wall, specifically the cathepsin family and their inhibitor, cystatin.  By 
understanding how the levels change, and how they are regulated, new therapeutic targets 
can be developed to retard plaque progression and aneurysmal formation and to save 
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LAMINAR SHEAR STRESS INHIBITS CATHEPSIN L ACTIVITY 
IN ENDOTHELIAL CELLS  
Introduction 
Vascular endothelial cells are constantly exposed to fluid shear stress, the 
frictional force generated by blood flow over the vascular endothelium. The importance 
of shear stress in vascular biology and pathophysiology has been highlighted by the focal 
development patterns of atherosclerosis in hemodynamically defined regions. For 
example, the regions of branched and curved arteries exposed to disturbed flow 
conditions including oscillatory and low mean shear stresses (OS) correspond to athero-
prone areas.  In contrast, straight arteries exposed to pulsatory, high levels of laminar 
shear stress (LS) are relatively well protected from atherosclerotic plaque development 
(1). 
  Changes in blood flow have been shown to be a critical factor inducing arterial 
remodeling (1-7).  Increases in arterial wall shear stress prevent vascular remodeling 
leading to thickening of the vascular wall and inflammation (2), while decreases in 
arterial wall shear stress promotes arterial remodeling and inflammation (2, 3).  
Additionally, low wall shear stress leads to degradation of the internal elastic lamina 
(IEL) (5).  Despite these findings, the underlying mechanisms by which shear regulates 
proteases degrading vessel wall matrix and lEL are not well described.  While there is a 
report demonstrating that shear regulates matrix metalloproteases (MMPs) in endothelial 
cells (8), it is not clear whether other proteases are also regulated by shear.  
 Cathepsins are the papain family of cysteine proteases which degrade elastin in 
addition to collagen (9).  Unlike MMPs, the role for cathepsins in blood vessel 
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remodeling and cardiovascular disease has been understudied until recently.  Cathepsins 
K, L, and S, potent elastinolytic proteases, have been identified in atherosclerotic plaques 
(10, 11) and in neointima following balloon angioplasty (12).  Furthermore, cathepsins B, 
L and S also have been shown to be upregulated at the transcriptional level in the arteries 
of Apolipoprotein E-null mice fed an atherogenic diet (13).  In addition, cathepsin 
activity is increased in abdominal aortic aneurysms (10, 14).    Cathepsin L is classified 
as one of the potent mammalian collagenases and elastases (15-18) and is capable of 
cleaving mature, insoluble elastin (17).  However, cathepsin L expression and its role in 
endothelial cells and atherosclerosis development are not well known.   
Here, we hypothesized that shear stress regulates cathepsin activities in 
endothelial cells. We examined the effects of OS and LS on matrix proteolytic activities 
and cathepsin activity in endothelial cells. Our results show that LS reduces matrix 
protease activity in a cathepsin L-dependent manner. 
Methods 
Mouse Aortic Endothelial cells (MAEC) culture and shear stress studies.  MAEC 
obtained from the thoracic aortas of C57/BL6 mice were isolated, cultured in growth 
medium [Dulbecco’s modified Eagle’s medium (DMEM) containing 20% fetal bovine 
serum (FBS), 100 µg/ml endothelial cell growth supplement (ECGS, Sigma) and 2.5 
U/ml heparin] as described(19), and used between passages 7-10. Confluent endothelial 
monolayers grown in 100-mm tissue culture dishes were exposed to an arterial level of 
uni-directional LS (15 dyn/cm2) or OS with directional changes of flow at 1 Hz cycle (± 5 
dyn/cm2) for 1 day by rotating a Teflon cone (0.5° cone angle) as described 
 33
previously(19). One hour prior to shear, the monolayers were washed and changed to 10 
ml of fresh shear medium (the growth medium without serum). 
 
Elastase and gelatinase assay.  Five µg/ml of BODIPY® fluorescein-conjugated DQ™ 
elastin or gelatin (Molecular Probes) in 5 ml of fresh serum-free DMEM was incubated 
with MAEC following exposure to OS, LS, or St for one day in the presence or absence 
of the cathepsin inhibitor E-64 (Sigma).  After an additional 24 hours, aliquots (200 µl) of 
conditioned media were assayed with a fluorescence plate reader, in triplicate, with 
background fluorescence subtracted from the no-cell negative control at 485 nm 
excitation and 525 nm emission. 
 
Cathepsin zymography.  Conditioned media were concentrated 20- to 30-fold with a 
spin concentrator (5kDa cutoff, Vivascience) and protein concentration was determined 
with a modified Lowry assay(20). Equal amounts of protein were resolved by 12.5% 
SDS-polyacrylamide gels containing 0.2% gelatin at 4°C.  Proteins were renatured in 50 
mM Tris buffer, pH 7.4 with 20% glycerol, and incubated overnight in assay buffer 
containing 0.1 M sodium acetate buffer, pH 5.5, 1 mM EDTA, and 2 mM 
dithiothreitol(21) in the presence or absence of cathepsin inhibitors: B (1 µM CA074), L 
(1 µM Z-FY(t-Bu)-DMK), K (1 µM 1,3-Bis(CBZ-Leu-NH)-2-propanone, Calbiochem), 
or S (1 nM Mu-Leu-Hph-VS-Ph)(22).  Gels were then rinsed with deionized water, 
stained with Coomassie Blue and destained, and analyzed by densitometry.  
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Cysteine protease active site labeling.  Conditioned media were normalized by volume 
and an equal aliquot (20 µl) was labeled with DCG-04 (5 µM), a biotinylated active site 
probe(23) (a gift from Dr. M. Bogyo) for 30 minutes before being boiled and resolved by 
a 12.5% SDS-PAGE.  Blotted membranes were then probed for biotin with the 
VectaStain Elite kit (Vector Labs).  Purified and denatured (boiled for 5 minutes) 
cathepsin L (Sigma) were used as positive and negative controls.  
  
Cathepsin activity assay.  Cells were lysed in 40 mM sodium acetate buffer, pH 5.5, 
.1% Triton-X 100, and conditioned media were collected and concentrated.  Aliquots 
were added to a reaction mixture containing 100 mM acetate, pH 5.5, 2.5 mM EDTA, 2 
mM dithiothreitol, and 0.1% Brij 35.  Benzyloxycarbonyl-Arg-Arg-7-amino-4-
methylcoumarin (Z-RR-AMC) (Biomol) was used as the substrate and added to attain a 
final concentration of 5 µM after the cathepsins were activated for two minutes at 
37°C(24).  The reaction mixture was incubated at 37°C for 10 minutes, and AMC 
fluorescence intensity was determined with a fluorescence plate reader (excitation at 360 
nm and emission at 460 nm). 
 
Western blots. Following shear, cells were lysed with RIPA buffer and conditioned 
media concentrated as above.  Equal amounts of total protein were resolved by SDS-
PAGE, and the blots were probed with antibodies to cathepsins L (1:500, R&D), K 
(1:200, Calbiochem), B (1:250, Calbiochem), and S (1:1000, Santa Cruz), or β-actin 
(1:1000, Santa Cruz) and appropriate secondary antibodies conjugated to alkaline 
phosphatase, which were detected by a chemiluminescence method(20). 
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Transfection of siRNA:  Sub-confluent (75-80%) MAEC were transfected with annealed 
siRNA duplex [sense: 5’-UCAUUGAGGAUCCAAGUCAtt, antisense: 5’-
UGACUUGGAUC CUCAAUGAtt] or non-silencing duplex [sense: 5’-
UUCUCCGAACGUGUCACGUtt, antisense: 5’-ACGUGACACGUUCGGAGAAtt] 
(Qiagen) using Oligofectamine (InVitrogen) in serum free medium.  After 6 hours, the 
medium was supplemented with serum (final 10% concentration) and cultured an 
additional 18 hours prior to exposing the cells to OS, LS, or no flow conditions. 
 
Statistical Analysis: Student’s unpaired t-test was used to establish significance between 
groups.  P<.05 was considered statistically significant. 
Results 
 
Figure 2.1.  LS decreases cell-associated gelatinase and elastase activities in MAEC.  
A, B) Confluent MAECs were exposed to Static (St), oscillatory shear (OS), or laminar 
shear stress (LS) for 1 day in serum free medium.  Following shear, BODIPY-elastin or -
gelatin were added to intact cells and incubated overnight in fresh media with or without 
50 µM E64.  Gelatinase (A) and elastase (B) activities measured as an increase in 
fluorescence intensity (mean ± SEM, *=p<.001, n=5 to 14).   
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LS decreases cell-associated extracellular matrix proteolytic activity in endothelial 
cells. 
To determine whether shear stress affected protease activities towards 
components of the extracellular matrix, we used BODIPY-gelatin and -elastin, soluble, 
fluorescently labeled gelatin and elastin, as matrix substrates to live endothelial cells that 
had been exposed to 24 hours of OS, LS, or no flow (static) conditions.  LS exposure 
significantly lowered both gelatinase and elastase activities in MAEC in comparison to 
those of static and OS-exposure (Figure 2.1A and B). In contrast, OS exposure had mixed 
effects on the matrix protease activities:  OS increased the gelatinase activity by 28% 
above that of the static control, but did not affect the elastase activity (Figure 2.1A and 
B). Next we examined how much of the total matrix protease activity was contributed by 
cathepsins using the cathepsin inhibitor E64.  Treatment with E64 inhibited the gelatinase 
and elastase activities by 30 to 50% in the static and OS-exposed cells.  On the other 
hand, E-64 did not have significant inhibitory effects on the gelatinase and elastase 
activities of LS-exposed cells (Figure 2.1A and B).  These results raise a possibility that 
LS and E-64 target the same proteases, cathepsins that may be novel members of the 
mechanosensitive matrix proteases. 
 
Endothelial cells exposed to LS have lower cathepsin activity than that of OS. 
Next, we determined whether the mechanosensitive cathepsin activities are 
secreted into the conditioned media or remain associated with the cells. For this study, 
conditioned media were collected from MAEC that were exposed to OS, LS and static 
conditions for 1 day, and the cells were scraped and lysed to measure protease activity in 
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the lysate.  The conditioned media and cell lysates were then used for three independent 
studies to determine cathepsin activities. 
First, we carried out the gelatin zymography at an acidic pH and calcium-deficient 
environment, a condition that is optimum for cathepsins (21).  The zymography using 








Figure 2.2.  MAEC exposed to LS have lower cathepsin activity than that of OS.  
Following 1 day of exposure of MAEC to OS, LS, or static conditions as in Figure 1, 
conditioned media (A) and cell lysates (B) were collected, and equal protein amounts 
were assayed by gelatin zymography optimized for cathepsins.  Representative 
zymograms show gelatinolytic activities at ~23 to25 kDa bands and densitometric 
quantification is shown in the bar graphs (mean ± SEM, n=7 to 9, *p< .05).  C: Equal 
volume of the conditioned media were labeled with the biotinylated active probe DCG-04 
(5 µM), resolved by SDS-PAGE, and the blot developed with a streptavidin-HRP 
method.  Purified and denatured (boiled) cathepsin L were used as positive and negative 
controls, respectively. As an additional control, the blots were reprobed with a cathepsin 
L antibody.  The biotin blot was quantified by densitometry as shown by the bar graph 
(n=3, p<.001).   
 
visible bands with apparent molecular masses of 23 to 25 kDa, indicating the presence of 
active proteases (Figure 2.2A and B).  In comparison, exposure of MAEC to LS 
significantly reduced the gelatinase activity in both the conditioned media and cell lysates 
(Figure 2.2A and B).  On the other hand, OS exposure showed a 2.5-fold increase in the 
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gelatinase activity in the conditioned media (Figure 2.2A).  This OS effect, however, was 
not observed in the cell lysate (Figure 2.2B).  
Second, the active protease activity associated with the 23/25 kDa proteins found 
in the conditioned media was further confirmed by an independent assay using DCG-04, 
which binds to active cathepsins (23).  As shown in Figure2C, the conditioned media 
obtained from OS exposed MAEC contained significantly higher amount of active 
cathepsins with ~25 kDa size in comparison to that of LS exposure.  As positive and 
negative controls, the purified active cathepsin L and the inactive (boiled) enzyme were 
used.  As expected, only active form of cathepsin L, but not the boiled enzyme bound to 
the DCG-O4 label (Figure 2.2C). Western blot of the same membrane showed that the 
amount of cathepsin L in the non-concentrated conditioned media of MAEC was not 
sufficient to be detected, although the DCG-O4 label clearly identified the enzymes.  
These results suggest that shear-sensitive cathepsin activity is secreted into the media as 
detected by the more sensitive assays (zymography and the DCG-O4 labeling study) 
although the Western blot study was not sensitive enough to show the enzyme identity.   
Cathepsin L activity is regulated by shear stress in endothelial cells.   
To further determine which cathepsin(s) was responsible for the shear-dependent 
matrix protease activity, we used four cathepsin inhibitors during the cathepsin gelatin 
zymography assay.  Again, the conditioned media of MAEC exposed to LS contained 
significantly reduced gelatinase activity in comparison to that of OS and static cells 
(Figure 2.3A).  The inhibitors of cathepsin B (CA074) and S (Mu-Leu-Hph-VS-Ph) had 
no effect on the gelatinolytic activity, while cathepsin K inhibitor [1,3-Bis(CBZ-Leu-
NH)-2-propanone] showed a minor inhibitory effect (Figure 2.3A).  The cathepsin L 
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inhibitor [Z-FY(t-Bu)-DMK], however, completely blocked the gelatinase activity of the 
conditioned media from both OS and static-exposed cells.   
 
Figure 2.3.  LS exposure inhibits cathepsin L activity in MAEC.  A) Following 1 day 
of exposure of MAEC to OS, LS, or static conditions, conditioned media were collected 
and analyzed by the cathepsin gelatin zymography in the absence or presence of the 
inhibitors of cathepsin B (1 µM CA074),  L (1 µM Z-FY(t-Bu)-DMK),  K (1 µM 1,3-
Bis(CBZ-Leu-NH)-2-propanone), or S (1 nM Mu-Leu-Hph-VS-Ph).  Shown zymograms 
are representative of at least 3 separate experiments. Equimolar active amounts of 
purified cathepsins L, B, K, and S were used in cathepsin gelatin zymography (B) and 
DCG-04 active cathepsin labeling (C).   
 
In this gelatin zymography study, there was a possibility that the reason we 
observed only cathepsin L-like activity may have been due to a bias in assay conditions.  
For example, the zymography requires renaturation of the cathepsins following non-
reducing SDS-PAGE.  If for any reason cathepsins do not properly renature, we would 
not be able to detect their activities. To address this question, we loaded a gelatin gel with 
equivalent amounts of purified cathepsins L, B, K, and S based on their cathepsin activity 
assays using the peptide substrate Z-FR-AMC and E-64 titration curve (24). Of the four 
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enzymes, only cathepsin L, but not B, K and S, was capable of degrading the gelatin 
(Figure 2.3B).  Active site labeling of the cathepsins showed that all four of the 
cathepsins were present in their active state (Figure 2.3C).  These results show that the 
cathepsin zymography condition used in this study is sufficient for cathepsin L activity 
while the other cathepsins may not be active, possibly due to their failure to be renatured 
during the zymography assay.  Based on these results, we cannot rule out whether 
cathepsins B, K, and S are mechanosensitive matrix enzymes or not.  Nevertheless, the 
pharmacological results suggest that cathepsin L activity in the conditioned media is a 
mechanosensitive matrix protease.      
 
Cathepsin L siRNA knocks down cathepsin L protein and significantly reduces 
endothelial gelatinase and elastase activity. 
  
To definitively address whether cathepsin L is a shear-sensitive matrix protease, 
we used a siRNA approach.  Treatment of MAEC with cathepsin L siRNA knocked 
down cathepsin L protein expression more than 80% below that of non-silencing controls 
in static, OS and LS-exposed cells as shown in Western blots of the conditioned media.  
To examine the specificity of the siRNA against cathepsin L, we immunoblotted the cell 
lysates with antibodies for cathepsins B, K, and S.   Cathepsin L siRNA did not cause 
nonspecific knockdown of cathepsin K and S (Figure 2.4A).  However, it reduced 
cathepsin B protein expression by ~50 %; cathepsin B exists as a 31 kDa single chain that 




Figure 2.4.  Cathepsin L siRNA knocks down cathepsin L protein and reduces 
endothelial cell-associated elastase activity.  Sub-confluent MAECs were transfected 
with cathepsin L specific siRNA (100 nM) or non-silencing RNA (non siRNA) 24 hours 
prior to shear exposure.  Transfected cells were then exposed to OS, LS, or static 
conditions for 1 day.  A) Cathepsin L protein knockdown by cathepsin L siRNA was 
confirmed by Western blot using conditioned media and the cathepsin L antibody with 
Coomassie staining of the gel as a loading control.  Cell lysates were collected and 
probed with antibodies to cathepsins B, K, and S, and a β actin antibody as an internal 
control.  In B, conditioned media obtained from A were examined by gelatin zymography 
as in Figure 2.  The arrows indicate cathepsin L bands.  The cell-associated gelatinase (C) 
and elastase (D) activities were determined using BODIPY-gelatin and -elastin as 




Under identical conditions, cathepsin L siRNA treatment of MAEC blocked the 
cathepsin L activity stimulated by OS in the conditioned media (Figure 2.4B).  This result 
provides strong evidence that the shear-sensitive gelatinolytic activity detected by the 
zymography is indeed cathepsin L.  Additionally, cathepsin L siRNA treatment of the 
cells significantly inhibited the static and OS-induced gelatinase and elastase activities as 
determined by the degradation of BODIPY-gelatin and –elastin.  Cathepsin L siRNA 
significantly inhibited both gelatinase and elastase activities of static and OS groups, 
although it tended to show a greater inhibitory effect on the elastase activity than the 
gelatinase (Figure 2.4B vs. 2.4C).  Cathepsin siRNA significantly reduced the gelatinase 
activity of static and OS groups by 25 and 30% of their non-silencing static and OS 
controls, respectively (Figure 2.4B).  In a similar trend, the siRNA significantly inhibited 
the elastase activity by 50 and 40% of the non-silencing control static and OS groups, 
respectively (Figure 2.4C). In contrast, the cathepsin L siRNA had no significant effect 
on the gelatinase or the elastase activity in cells exposed to LS.  These results are 
consistent with the E-64 results (Figure 2.1), suggesting that cathepsin L is an important 
shear-dependent matrix protease. 
 
Shear stress does not affect cathepsin B activity in endothelial cells. 
With the above cathepsin L siRNA results, there remained a question whether the 
reduction in the gelatinase and elastase activities by cathepsin L siRNA treatment was 
caused by an unexpected partial knockdown of cathepsin B.   Therefore, we decided to 
examine whether cathepsin B is a shear-sensitive protease.  For this purpose, we used the 
cathepsin B specific peptide substrate, Z-RR-AMC to assess cathepsin B activity.  The 
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results showed that neither LS nor OS significantly changed cathepsin B activities from 
that of the static conditions in either the cell lysates (Figure 2.5A) or conditioned media 
(Figure 2.5B) obtained from MAEC.  Next, we examined whether the cell-permeable 
cathepsin B inhibitor (CA074Me) would reduce the cell-associated elastase activity.  For 
this study, we treated MAEC with CA074Me at 0.1 µM, a concentration that inhibits 
cathepsin B activity by ~70% (Figure 2.5C) without significantly affecting purified 
cathepsin L activity (data not shown).  At this concentration, the cathepsin B inhibitor 
had no effect on the cell-associated elastase activities of the cells exposed to the static, 
OS and LS conditions (Figure 2.5D). These results not only show that cathepsin B 
activity is not regulated by shear stress, it also indicates that this enzyme does not play a 
critical role in the elastase activity associated with MAEC.   Together, the results shown 
in Figures 2.3 and 2.4 strongly support the conclusion that the cathepsin L siRNA 
treatment inhibited the elastase activity in static and OS-exposed cells by knocking down 




Figure 2.5. Cathepsin B activity is not affected by shear stress in MAEC.  Equal 
protein aliquots of the cell lysates (A) and conditioned media (B) obtained from MAEC 
exposed to static, LS or OS for 1 day were incubated with the synthetic peptide substrate 
Z-RR-AMC specific for cathepsin B in acidic pH conditions.  C. Static cell lysates were 
incubated with Z-RR-AMC as in A with the increasing concentrations of CA074Me. D. 
Following exposure of MAEC to static, OS, or LS for 1 day, cells were further incubated 
for 18 hr in fresh media containing BODIPY-gelatin with or without 0.1 µM CA074Me 
(mean ± SEM, *p< 0.05, n=4 to 6).  ns: statistically not significant 
 
Discussion 
The novel and significant findings of this study are that: 1) exposure to 
atheroprotective LS decreases elastase and gelatinase activities of endothelial cells, 2) 
cathepsin L activity is inhibited by LS and is responsible in part for shear stress regulated 
matrix protease activity, and 3) cathepsin B activity is not regulated by shear stress and it 
does not significantly contribute to the elastase activity.   These conclusions are 
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supported by several lines of evidence.  Using fluorescent-gelatin and –elastin as 
substrates added to live cells, we have shown that LS exposure substantially inhibited 
their degradation compared to OS and static cultured cells, and that these proteolytic 
activities were inhibited by E-64.  It should be noted that LS exposure lowered the 
protease activity to a minimum such that it could not be significantly further inhibited by 
a general cathepsin inhibitor E-64 or cathepsin L siRNA in this study. In addition, the 
gelatin zymography optimized for cathepsins and the active site labeling study with 
DCG-04 revealed that active cathepsins were produced and secreted in static and OS-
exposed cells, while LS significantly reduced matrix proteolytic activities and cathepsin 
L, but not cathepsin B.  
Evidence supporting the mechanosensitive regulation of cathepsin L was provided 
by the pharmacological and cathepsin L siRNA studies. The cathepsin B and S inhibitors 
had no effect on the gelatinolytic activity in the zymography using the conditioned media 
(Figure 2.2).  Although it was partially reduced by the K inhibitor, the L inhibitor 
completely blocked all the activity, suggesting cathepsin L as the predominant proteolytic 
enzyme in that condition.  It is important to note that the cathepsin zymography used in 
our study turned out to be effective for cathepsin L activity, but not for cathepsins K, B 
and S (Figure 2.2).  Therefore, the partial effect of the cathepsin K inhibitor observed in 
Figure 3A is likely due to its non-specific effects on cathepsin L.  We further suggest that 
cathepsin L is an enzyme responsible for the shear-sensitive gelatinolytic activity of the 
cell lysate and the conditioned media determined by the zymography (Figure 2.1).    
The significant effect of cathepsin L siRNA in knocking down cathepsin L 
expression and gelatinase and elastase activities further supports its role as a 
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mechanosensitive protease. This interpretation was somewhat complicated by the 
unexpected effect of the siRNA on cathepsin B, requiring further studies.  Importantly, 
however, our further studies revealed that cathepsin B activity did not change by LS or 
OS in MAEC, nor did it contribute to the elastase activity associated with the cells as 
shown by the lack of the cathepsin B inhibitor effect on it.  These results again support 
the conclusion that cathepsin L, but not cathepsin B, is an important shear-sensitive 
matrix protease in endothelial cells.    
The role for cathepsins and their inhibitor cystatin C in elastic lamina degradation, 
vascular remodeling and atherosclerosis has been demonstrated in animal models and 
humans.  Mice deficient in cathepsin S in LDLR-null mice show decreased internal 
elastic lamina (IEL) fragmentation and reduction in atherosclerosis (26).  Cystatin C 
deficiency in ApoE-null mice resulted in increased elastic lamina fragmentation and 
collagen content, which could have contributed to the dilation of thoracic and abdominal 
aortas (27).  It remains controversial whether cystatin C deficiency affects atherosclerosis 
(28, 29).  Increased cathepsin L expression and decreased cystatin C have been found in 
human atherosclerotic plaques and aortic aneurysms (10, 30).   
The differential effects of laminar and oscillatory shear stresses on cathepsin L 
activity reported in this study may be a critical mechanism by which AAA occurs in 
regions of disturbed flow. Several human and animal studies have demonstrated that 
atherosclerotic lesions and aneurisms of the abdominal aorta occur in the regions where 
they are exposed to unstable flow conditions including flow reversal, low mean wall 
shear stress and high oscillatory shear index (31-35).  In contrast, relatively high levels of 
laminar shear stress were shown to reduce AAA progression in rat experimental 
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models(36) and a recent report found increased cathepsin L levels in human AAA but 
almost no detectable cathepsin L in normal arteries (10). Together, these previous 
findings and our current study raise an interesting possibility that differential regulations 
of cathepsin L by undisturbed and disturbed flow conditions may play a critical role in 
the protection or initiation and progression of AAA. 
Shear stress potently regulates vascular remodeling, including the sizes of lumen 
and IEL fenestrae (3, 6, 7, 37), and flow-dependent arterial remodeling is endothelium-
dependent(3).  While the mechanisms controlling cathepsin activities in smooth muscle 
cells (11) and macrophages (22, 38, 39) have been reported, the role of cathepsins in 
endothelial cells have been rather limited.  Shi et al showed that cathepsin S deficiency 
led to abnormal angiogenic responses due to abnormal extracellular matrix degradation 
(39).  Also, cathepsin L has been shown to play an important role in endothelial 
progenitor cell mediated neovascularization (37).   While shear stress has been shown to 
increase cathepsin B activity in neutrophils, (40) the current study is the first report 
showing that cathepsins are regulated by shear stress in endothelial cells.  The reason that 
cathepsin B is shear-sensitive in neutrophils but not in endothelial cells as we showed 
here may be due to unique cell-specific responses. 
Shear stress has been shown to regulate another family of matrix proteases, 
MMP’s both in cultured endothelial cells and in animal models.  OS, but not LS, 
significantly stimulates MMP-9 mRNA and protein expressions in murine lymphoid 
endothelial cells (8).  Consistent to that report, we also found that OS stimulated MMP2/9 
activities in MAEC as measured by gelatin zymography (data not shown).  Using an 
arterio-venous fistula model in wild-type and knockout mice, flow-induced vascular 
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remodeling has been shown to involve MMP activity that is mediated by the NADPH 
oxidases and nitric oxide-dependent mechanisms (41).  In a rabbit model using a carotid 
branch ligation method, low flow was shown to upregulate MMP-2 and MMP-9 (42) . 
Shear stress regulates structure and function of endothelial cells and plays an 
important role in atherosclerosis development. The atheroprotective LS may protect the 
integrity of elastic laminae and extracellular matrix by inhibiting cathepsins such as L, 
while the pro-atherogenic OS have opposite effects. In summary, we showed that 
cathepsin L is a mechanosensitive matrix protease with a potential importance in vascular 
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ROLE OF CATHEPSIN L IN ENDOTHELIAL CELL ALIGNMENT 
AND ELONGATION 
Introduction 
Endothelial cells line the arterial wall and are directly exposed to the fluid shear 
stress of the blood as it drags along the wall.  This shear stress elicits several responses in 
the endothelial cell, including elongation and alignment in the direction of flow, 
presumably to reduce the local mechanical load and injury.  At sites of disturbed flow 
such as bifurcations and sharp turns where there are regions of flow separation and 
recirculation, the endothelial cells remain unaligned; this has been demonstrated both in 
vivo and in vitro.  Several signaling proteins and pathways are involved in endothelial 
alignment including mechanosensory complexes to detect the flow and its direction (1), 
actin and microtubule cytoskeletal components to reorient the cell (2), calcium influx (2), 
and integrin activation to establish new focal adhesions and signaling complexes (3, 4).  
Microtubule disruption (2) and inhibition of p38 mitogen activated protein kinase (5) 
both block endothelial cell alignment.  It has recently been shown that vascular 
endothelial cadherin, platelet endothelial cell adhesion marker-1, and vascular endothelial 
growth factor receptor 2 were sufficient to induce alignment in the direction of flow when 
transfected into COS 7 African green monkey cells that do not normally have this 
response (1).  
Formation of new integrin-ligand complexes have also been shown to be 
upstream of Rho signaling and to participate in EC alignment with flow (3). 
Establishing new integrin-ligand complexes may also involve remodeling of matrix.  
Alpha V beta 3 integrin has increased activation and affinity in response to shear stress 
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(3) and blocking it with a peptide antagonist reduces flow-mediated vasodilation (6).  
This integrin is also functional in angiogenesis and tumor metastasis, serving to bind 
MMPs at the cell surface in migrating cells (7).  It also binds mature cathepsin S, which 
is capable of degrading several extracellular matrix components, on the surface of 
vascular smooth muscle cells (8). 
Integrin dissociation and reattachment to extracellular matrix components may 
also involve breakdown and reorganization of basement membrane matrix, but protease 
involvement in endothelial cell alignment and elongation has not been investigated.  An 
initial finding that knockdown of cathepsin L with siRNA inhibited EC elongation and 
alignment while performing other studies, led us to develop the hypothesis that cathepsin 
L is involved in alignment of endothelial cells.  We show here that knockdown of 
cathepsin L with siRNA but not pharmacological inhibitor blocks EC alignment and 
elongation and also alters p38 and ERK signaling mechanisms in the endothelial cell.   
Methods 
Mouse Aortic Endothelial cells (MAEC) culture and shear stress studies.  Endothelial 
cells obtained from the thoracic aortas of C57/BL6 control were isolated and cultured in 
growth medium growth medium [DMEM containing 20% fetal bovine serum (FBS), 100 
µg/ml endothelial cell growth supplement (ECGS, Sigma) and 2.5 U/ml heparin)] as 
described previously (9) and used between passages 7-10. Confluent endothelial 
monolayers grown in 100 mm tissue culture dishes were exposed to an arterial level of 
uni-directional LS (15 dyn/cm2) or OS with directional changes of flow at 1 Hz cycle (± 5 
dyn/cm2) by rotating a Teflon cone (0.5° cone angle) as described previously by us (10) 
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One hour prior to shear, the monolayers were washed and changed to 10 ml of fresh shear 
medium (the growth medium without serum). 
 
Western blots. Following shear exposure, conditioned media were collected and 
normalized to 10 ml total with fresh serum free shear media if necessary, and 
concentrated 20 to 30 fold with a spin concentrator (5 kDa molecular weight cutoff, 
Vivascience).  Cells were rinsed twice with phosphate buffered saline, lysed with RIPA 
buffer, and sonicated briefly.  Following modified Lowry protein assay, equal amounts of 
total protein were resolved by SDS-PAGE.  Protein was transferred to a 
polyvinyldifluoride membrane (Millipore), and probed with a rabbit polyclonal anti- 
phosphorylated p38, total p38,  ERK 42/44, phosphorylated ERK 42/44, JNK, and 
phosphorylated JNK (1:1000, Cell Signaling) and a secondary antibody conjugated to 
alkaline phosphatase (Bio-Rad), which were detected by a chemiluminescence method 
(11). 
 
Transfection of siRNA:  Sub-confluent (75-80%) MAEC were transfected with annealed 
siRNA duplex [sense: 5’-UCAUUGAGGAUCCAAGUCAtt, antisense: 5’-
UGACUUGGAUC CUCAAUGAtt] or non-silencing duplex [sense: 5’-
UUCUCCGAACGUGUCACGUtt, antisense: 5’-ACGUGACACGUUCGGAGAAtt] 
(Qiagen) using Oligofectamine (InVitrogen) in serum free medium.  After 6 hours, the 
medium was supplemented with serum (final 10% concentration) and cultured an 
additional 18 hours prior to exposing the cells to OS, LS, or no flow conditions. 
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Phalloidin staining.  Cells were rinsed with PBS, and fixed with 4% paraformaldehyde 
in PBS for 10 min at room temperature.  Cells were permeabilized with 0.2% Triton X-
100 in PBS, and the fixative was quenched with 50 mM ammonium chloride.  Blocking 
buffer of 3% BSA in PBS was preincubated with the cells for an hour, then incubated 
with rhodamine-phalloidin (1:100) dilution.  Cells were rinsed with PBS then covered 
with Prolong anti-Fade Kit (Molecular Probes) and visualized on an epifluorescent 
microscope. 
 
Alignment and elongation calculation.  Images of four different fields were captured of 
either the light micrograph, or the fluorescent image of the phalloidin labeled cells.  LSM 
Image software (Zeiss) was used to draw a line in the direction of the stress fibers seen in 
the phalloidin labeled cells to determine its angle with the direction of flow.  Randomly 
aligned cells approach an orientation angle of 45°, and aligned cells’ angle goes to 0°.  
For elongation, the software was used to measure the cell perimeter and the area of the 
cells.  The cell shape index was calculated according to the equation 4π x cell area/(cell 
perimeter)2.  As the cells elongate, the shape index goes to zero but it goes to 1 if they are 
perfect circles (5). 
 
Statistical Analysis. Student’s unpaired t-test was used to establish significance between 





Figure 3.1.  Cathepsin L siRNA blocks endothelial cell alignment in response to LS.  
Confluent MAECs were exposed to 24 hours of OS, LS, or St conditions.  Representative 
micrographs are shown. 
 
Knocking down cathepsin L blocks endothelial cell alignment and elongation in 
response to laminar shear stress.   
In our previous studies using cathepsin L siRNA to study ECM proteolytic 
activity (12), we found that the endothelial cells transfected with cathepsin L siRNA did 
not elongate and align in response to LS (Figure 3.1) but those transfected with a 
nonsilencing RNA do.  This illustrated that the transfection protocol was not causing this 
phenomenon but led us to question whether the loss of cathepsin L was responsible.  
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Transfection with cathepsin K siRNA does not block this morphological change (Figure 
8.1).  We repeated this experiment and quantified endothelial cell alignment and 
elongation.  MAEC were transfected with cathepsin L siRNA 24 hours prior to exposure 
to LS or no flow conditions for 24 hours.  Then digital images of the cells were captured 
(Figure 3.2).  Other cells were fixed and stained with rhodamine-phalloidin to visualize 
the actin cytoskeleton.  Alignment to direction of flow and the index of elongation were 
calculated as described (5).  MAEC with cathepsin L knocked down showed a 
significantly higher  cell shape index indicating no elongation and also had a significantly 
higher angle of alignment illustrating they are not aligning with the direction of flow 
(Figure 3.3).   
Since cathepsin L has been demonstrated by us to play a role in degradation of 
ECM (12), we hypothesized that reduction in that activity with siRNA led to a loss of 
remodeling ability of the ECM and as a consequence, alignment.  We used a cathepsin L 
pharmacological inhibitor to test this as well.  Surprisingly, the MAEC still elongated and 
aligned in the presence of 10 µM of the cathepsin L inhibitor, which did not support the 












Figure 3.2.  Cathepsin L inhibitor does not block endothelial cell elongation and 
alignment in response to LS.  MAECs were transfected with non-siRNA or cathepsin L 
siRNA, or were incubated with cathepsin L inhibitor or vehicle, and exposed to 24 hours 







Figure 3.3.  Cathepsin L inhibitor does not block endothelial cell elongation and 
alignment in response to LS.  MAECs were transfected with non-siRNA or cathepsin L 
siRNA, or were incubated with cathepsin L inhibitor or vehicle, and exposed to 24 hours 
of LS and then fixed and stained with Rhodamine-phalloidin to visualize the F-actin 
structures.  Representative micrographs are shown.  Cell alignment and elongation were 




 To expand on the finding that cathepsin L knockdown impeded matrix remodeling for 
morphology change, we used a scratch wound assay to determine the role of cathepsin L 
in EC migration.  Under static conditions, EC were transfected with cathepsin L siRNA 
24 hours prior to replacing medium with serum free medium and scratching the confluent 
layer of cells.  Cells were incubated for 18 hours and digital images were captured to 
view cell migration into the wounded area.  Knocking down cathepsin L inhibited EC 
migration into the wound pathway as seen in Figure 3.4. 
 
Figure 3.4.  Knockdown of cathepsin L inhibits MAEC migration after scratching.  
Static culture MAECs were transfected with cathepsin L siRNA 24 hours prior to 
scratching the monolayer.  Images were captured and compared to 18 hours later.  Bars 






Cathepsin L knockdown and MAP kinases 
 Cathepsin L has not been reported as playing a role in EC migration or alignment so it 
became important to find a mechanism.  Sumpio’s group reported that blocking p38 
MAPK with a pharmacological inhibitor blocked EC alignment in bovine aortic 
endothelial cells using a pharmacological inhibitor.  We investigated if p38 was upstream 
or downstream of cathepsin L in shear mediated EC alignment.  MAEC were transfected 
with either cathepsin L siRNA or nonsiRNA and exposed to LS or no flow for 24 hours.  
There was an elevated baseline phosphorylation of p38 after knocking down cathepsin L 
both under no flow conditions and after 24 hours of LS exposure (Figure 3.5 A, C).   
MAP kinases are known to be involved in several signaling pathways, some of 
which are activated by shear stress in short time periods on the scale of minutes.  This 
immediate activation leads to downstream effects of transcription and translation of key 
proteins. We examined the short term activation of p38 in response to LS and if knocking 
down cathepsin L would alter this time course of activation.  MAEC transfected with 
cathepsin L siRNA or nonsiRNA were sheared for 0, 15, 30, 60 minutes or 24 hours, 
lysed and probed for p38 phosphorylation.  Peak p38 activation was seen after 30 minutes 
of LS in those cells transfected with the non-silencing control, but knockdown of 
cathepsin L induced an earlier activation after only 15 minutes of LS (Figure 3.5A).  
There was also a higher baseline elevation of p38 phosphorylation at 0 hours and 24 
hours of LS (Figure 3.5 A, C).  Extracellular signal regulated kinase (ERK) has been 
studied in endothelial cells in response to shear stress and been linked to various shear 
stress signaling pathways. Baseline ERK activation was also increased in the MAEC with 
reduced cathepsin L levels at 0 hours and 24 hours of LS similar to p38 (Figure 3.5B).  
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An earlier peak activation of ERK occurred as well after 15 minutes of shear stress 
instead of the 30 minute time point seen in the control MAEC.  JNK phosphorylation was 
not altered by transfection with cathepsin L siRNA (Figure 3.5D). 
 
 
Figure 3.5.  Knockdown of cathepsin L alters peak phosphorylation of MAP kinases.  
MAECs were transfected with either cathepsin L siRNA or nonsiRNA and exposed to LS 
for 0 min, 15 min, 30 min, or 24 hours.  Cell lysates were probed for phosphorylation of 




These results illustrate a role for cathepsin L in endothelial cell alignment and 
elongation.  Novel findings here are that (1) knockdown of cathepsin L with siRNA 
blocks EC alignment and elongation in response to laminar shear stress; (2) Cathepsin L 






to elevated p38 and ERK activation but does not affect JNK suggesting that p38 and ERK 
are involved either upstream or downstream of cathepsin L dependent EC migration. 
 Rearrangement of ECM proteins underlying endothelial cells occurs in response to 
laminar shear stress (13), and cathepsin L is capable of degrading these matrix 
components necessary for remodeling of the basement membrane and subsequent cell 
alignment and migration.  Molecular biological knockdown of cathepsin L with siRNA 
affected EC alignment, but the cathepsin L inhibitor had no significant effect.  Chapman 
et al showed cells can create intimate microenvironments for enzyme function that are 
not penetrable by soluble inhibitors using alveolar macrophages that were capable of 
degrading insoluble fibrin whether the cells made contact with it or not in the absence of 
proteinase inhibitors.  However, in the presence of the inhibitors, the macrophages could 
still degrade the fibrin but only when in contact with it (14).  Here, we saw that the 
molecular biological knockdown of cathepsin L with siRNA could block the EC 
alignment but the soluble inhibitor did not; it could be that the siRNA reduces the protein 
level so that there is no cathepsin L to work at the microenvironment, whereas, with the 
addition of the inhibitor, functional cathepsin L is present in the cell, but the sequestration 
of the inhibitor from the functional site of matrix remodeling allows the cells to elongate 
and align. 
Cathepsins have been canonically referred to as the lysosomal cysteine proteases, 
but much research has revealed their involvement in other cellular processes both intra- 
and extra-cellularly.  Particularly, cathepsin L has been shown to have a surprising role in 
the cell nucleus where it cleaves a transcription factor CDP/cux that serves to regulate the 
cell cycle (15).  To this end, we conclude that cathepsin L is playing a role in endothelial 
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cell alignment with the direction of flow and have observed the signaling mechanisms 
involved after cathepsin L knockdown implicating p38 MAPK and ERK 1/2.  Early 
activation of these kinases in response to shear stress leads to downstream events later, 
and both have been shown to regulate cathepsins in other systems.  p38 MAPK has been 
shown to be essential for expression of cathepsin K in maturing osteoclasts after RANKL 
induction (16). 
 Tumor studies of cathepsin L implicate the Ras- Raf- MAPK/ERK(MEKs) – 
ERK1/2 pathway in cathepsin L expression and activation  where constitutively active ras 
expression led to increased protein levels of cathepsin L in fibroblasts through the 
Raf/ERK pathway which was necessary (17).    Sustained ERK activation by the cell 
adhesion molecule L1 increased alpha V beta 3 integrin, cell motility, and cathepsin L, 
again linking ERK activation and cathepsin L (18).  Increased ERK activation increased 
cathepsin L dependent motility of transformed NIH 3T3 fibroblasts with decreased JNK 
activity, but when there was increased JNK activity and decreased ERK activity, the 
proteolysis switched to urokinase plasminogen dependent motility (19).  Knockdown of 
cathepsin L in our system causes ERK and p38 to be turned on, but JNK is not. 
Cathepsin L contribution to the ECM remodeling that occurs during EC alignment 
and migration deserves further investigation to understand the proteolytic mechanisms 
that take place under flow conditions.  Our earlier findings show that endothelial cells 
actually decrease the activity of cathepsin L intracellularly and extracellularly under LS, 
but there may be a basal level of cathepsin L that is used at either integrins or focal 
adhesions to facilitate migration and alignment.  Co-localization and co-
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CYCLIC PRESSURE AND SHEAR STRESS REGULATE 
MATRIX METALLOPROTEINASES AND CATHEPSIN 
ACTIVITY IN PORCINE AORTIC VALVES 
Introduction 
Heart valve disease is a serious condition that affects a significant percentage 
of the population both in the U.S and worldwide. According to the American Heart 
Association statistics, valvular diseases cause nearly 20,000 deaths per year and are 
related to another 42,000 deaths. Current surgical interventions include valve repair 
or replacement depending on the diagnosis.  Significant progress has been made 
during the last century on the development and improvement of prosthetic valves; 
however, so far there is no ideal replacement valve available. Recent advances in 
tissue engineering have spurred the interest in heart valve tissue engineering. The 
success of a tissue engineered heart valve (TEHV) will rely heavily on the 
understanding of native valve biology, which unfortunately, has only been studied 
very limitedly.   
Native heart valves, the aortic and the mitral valves in particular, function in a 
harsh and complex mechanical environment. The valvular structure constantly 
responds to the surrounding mechanical environment. Close correlations between 
mechanical stresses and heart valve biology have long been documented by clinical 
observations and animal studies (1-3). According to these studies, the structural 
components of the aortic valve undergo constant renewal in response to mechanical 
loading (1), and the sites of protein and glycosaminoglycan synthesis in the leaflets 
correlate with the functional stresses (2). Similarly, changes in mechanical loading 
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alter biosynthetic behavior of valve cells. For instance, collagen synthesis in mitral 
valve leaflets was enhanced as a result of altered stress distribution due to left 
ventricular infarctions (4). Although, it is obvious that mechanical factors play a very 
important role in heart valve biology, so far, there is a paucity of literature concerning 
this subject. These studies have shown that cultured porcine aortic valvular cells 
responded to applied shear stress in a very unique way (5). Moreover, the 
mechanotransduction pathway seems to be different from the extensively studied 
vascular cell counterparts (5, 6). Previous studies in our laboratory showed that 
elevated pressure, both steady and cyclic, caused enhanced ECM synthesis in porcine 
aortic heart valve leaflets (7, 8).  It is clear from these studies that mechanical factors 
such as pressure and shear stress are important in valve ECM remodeling; however, 
the molecular mechanisms remain largely unexplored.  An increase in ECM synthesis 
accompanied by a decrease in ECM degradation may be induced by reducing enzyme 
activity of MMPs and cathepsins or by regulating their activity through protein 
inhibitors of these proteases. 
Cathepsin L is a member of the papain family of lysosomal cysteine proteases, 
first identified in lysosomes, but has been also found to have functions in other 
cellular compartments, including the nucleus (9), and even extracellularly in different 
disease conditions such as arthritis (10, 11) and cancer (12). Intracellularly, cathepsin 
L is a powerful protease involved in protein turnover; extracellularly, cathepsin L is a 
powerful collagenase and elastase necessitating its tight regulation by pH, reducing 
environment, and protein inhibitors.  In the cardiovascular system, cathepsin L has 
been found to be active within abdominal aortic aneurysms and atherosclerotic 
72 
lesions (13), while the absence of cathepsin L in knockout mice causes dilated 
cardiomyopathy (14) once again showing that although initially found in lysosomes, 
this protease is involved in other aspects of physiology.  We have recently shown that 
steady laminar shear inhibits cathepsin L activity in mouse aortic endothelial cells 
(15).  Other cathepsins have been linked to cardiovascular disease as well, 
particularly cathepsins S and K, which have been linked to elastic lamina degradation 
during atherosclerosis plaque development (16, 17), as well as in myxomatous heart 
valves (18). 
 The MMP family of proteases is another large member family that has been 
studied in the context of vascular remodeling (19-21)  and in valvular remodeling (18, 
22, 23) . 
In the current study, we examined the hypothesis that MMPs and cysteine-
dependent cathepsins are regulated by the mechanical environment, particularly 
pressure and steady laminar shear stress. We exposed the fresh porcine aortic valve 
leaflets to the highest pressure tested (mean of 170 mmHg, 1.167 Hz), and steady 
laminar shear stress of 25 dyne/cm2.  These were the same pressure and shear stress 




Tissue collection and culture.  Fresh porcine aortic valves were obtained aseptically 
from a local slaughterhouse (Holifield Farm, Covington, GA) and transported to the 
laboratory in ice-cold sterile Dulbecco’s Phosphate Buffered Saline (DPBS) 
(BioWhittaker, Walkersville, MD). The three leaflets were cut from the annulus and 
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were bisected at the mid-line. One half was subjected to cyclic pressure or steady 
shear stress, and the other half was exposed to atmospheric pressure to serve as a 
control. Each experiment was run for 48 hrs, with a sample size ranging from 6 to 10 
leaflets.  
 
Cyclic pressure and shear stress experiment.  Valve tissue was put in 12-well 
tissue culture plates and placed in an in-house designed polycarbonate pressure 
chamber (7, 8).  The tissues were exposed to pressure conditions (150-190mmHg, at a 
frequency of 1.167 Hz) for up to 48 hrs. For shear stress studies, valve leaflets were 
mounted onto a modified parallel plate (24), with the ventricular surface facing flow. 
Steady laminar shear stress of 25 dyne/cm2 was applied onto the leaflets for 48 hrs. 
Control leaflet tissues were placed in 12 well plates with 3 ml DMEM in each well. 
They were incubated under static conditions at 37oC, 5% CO2 and atmospheric 
pressure. 
 
Gelatin zymography and immunoblot.  Following mechanical exposure, half of a 
porcine aortic valve leaflet tissue was solubilized in lysis buffer (in mmol/L: Tris-HCl 
20 (pH 7.5), EGTA 5, NaCl 150, glycerol-phosphate 20, NaF 10, sodium 
orthovanadate 1, 1% Triton X-100, 0.1% Tween 20) (20) and centrifuged at 14,000 
rpm.  Supernatant (lysate) was assayed for protein concentration with modified 
Lowry assay and equal amounts of protein (20µg) were loaded into 12.5% SDS-
PAGE with 0.2% gelatin and electrophoresed at 4°C.  Proteins were renatured in 50 
mM Tris buffer, pH 7.4 with 20% glycerol for cathepsins or 2.5% Triton-X for 
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MMPs, and incubated overnight in assay buffer containing 0.1 M sodium acetate 
buffer, pH 5.5, 1 mM EDTA, and 2 mM dithiothreitol (DTT)(25) with or without the 
presence of 1 µM E-64, the cathepsin inhibitor or in 50 mM Tris-HCl pH 7.4, 10 mM 
CaCl2, 50 mM NaCl, and 0.05% Triton X-100 for MMPs.  Gels were then rinsed with 
deionized water and stained with Coomassie. 
Aliquots of lysates were also loaded into 12.5% SDS-PAGE without gelatin 
and transferred to a polyvinyldifluoride (PVDF) membrane.  Membranes were probed 
with a goat anti-cathepsin L primary antibody (R&D) and then with a rabbit anti-goat 
secondary antibody conjugated to alkaline phosphatase.  CDP-Star reagent was added 
and chemiluminescence was detected with photographic paper. 
 
Cathepsin activity assay.  Remaining half of the porcine aortic valve leaflet tissue 
was homogenized in a 0.15 M NaCl solution and centrifuged at 14,000 rpm for 15 
minutes followed by modified Lowry protein assay on the supernatant.  Activity 
assay procedure has been modified from that previously published(26): Brij 35 at 
0.1% (Sigma) was added to 25 µg of total protein in a final concentration of 100 mM 
acetate, pH 5.5, 2.5 mM EDTA, 2 mM DTT for two minutes at 37°C to activate 
cathepsin L.  Then Z-FR-AMC (Biomol), a synthetic substrate susceptible to 
cathepsin L hydrolysis, was added to a final concentration of 5 µM for ten minutes 
prior to reading AMC fluorescence released in a 96-well plate with excitation at 360 
nm and emission at 460 nm. 
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Immunohistochemistry.  Leaflet tissues were snap frozen in liquid nitrogen for 
cathepsin immunohistochemistry (IHC).  The orientation of the leaflet was controlled 
by holding the tissue upright so that the cross section contained the three layers while 
placing it in the viscous media (OCT), and then the block was quickly dipped into 
liquid nitrogen.  The block was cut into 7µm sections and stored under –80oC until 
staining.   Separate leaflets were embedded in paraffin and sectioned for MMP IHC. 
Frozen sections were thawed at room temperature and then immersed in acetone for 5 
minutes. The slides were then washed in PBS twice, 5 minutes each, followed by 
immersing in 0.3% H2O2 for 15 minutes to block the endogenous peroxidase. After 
this step, the slides were incubated in 2% BSA/PBS for 15 minutes to suppress non-
specific binding. The blocking step was followed immediately by primary antibody 
incubation (anti-cathepsin L, dilution of 1:20, Santa Cruz, S6501, anti-MMP-2, 
dilution of 1:50 (Calbiochem) or anti-MMP-9, dilution of 1:50 (Calbiochem) for 1 
hour followed by 2 washes in PBS, each for 5 minutes. Next was the secondary 
antibody incubation (anti-goat IgG, 1:400) for 30 minutes, followed by 2 washes in 
PBS and then incubation in ABC-peroxidase (Vector Lab) for 1 hour. Subsequently, 
the slides were incubated in DAB (Vector Laboratories, SK-4100, Burlingame, CA) 
until color developed, the exact time varies with the amount of antigen in the tissue, 
but total development time was less than 10 minutes. Slides were then washed in 
water for 5 minutes and counterstained with hematoxylin. Cytoseal 60 (Richard Allan 
Scientific) was used as a resinous mounting agent, and the slides were covered and 
allowed to dry overnight before viewing with a Nikon Eclipse E600w microscope. 
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Results 
Cyclic pressure inhibits cathepsin L and MMP2/9 activity in aortic heart valves.   
Aortic heart valve leaflets were cultured for 48 hours under 170 mm Hg cyclic 
pressure before homogenization.  Gelatin zymography showed a 37% decrease in 
cathepsin activity under cyclic pressure in comparison to that of the static control 
(Figure 4.1B).  The cathepsin inhibitor, E64, completely blocked the gelatinase 
activity, demonstrating it is cathepsin activity.  The decrease in cathepsin activity was 
not due to the change in cathepsin L protein level as shown by Western blotting with 
the specific antibody (Figure 4.1A).  MMP2/9 activity showed a minor, but 
significant decrease of 17% by cyclic hypertensive pressure (Figure 4.1C).  Fresh 
aortic valve leaflets contained minimal proMMP-2 activity and some cathepsin L 
activity (Figure 4.1D). 
 
Cathepsin L is expressed throughout the aortic valve leaflet.   
We next examined whether cyclic pressure affects cathepsin L expression in 
the aortic valve leaflets and its location.  As shown by the IHC staining with the 
cathepsin L antibody in Figure 4.2, cathepsin L protein was diffusely expressed in the 
spongiosa, ventricularis, and fibrosa regions when cultured under atmospheric (Figure 




Figure 4.1.  Cyclic pressure decreases cathepsin L activity in aortic valve leaflets.  
Fresh porcine aortic valve leaflets were exposed to hypertensive pressure (cyclic: 
1.167 Hz, 170 mmHg) or control (atmospheric pressure) for 48 hrs. Equal protein 
amount of leaflet lysates was analyzed by western blotting with the cathepsin L 
antibody (A) and gelatin zymography for cathepsins B) or for MMPs (C). Shown in A 
and B are a representative Western blot and gelatin zymography in the absence 
(upper) or presence (lower) of E-64.  The bar graph shows gelatinase activity as 
determined by densitometric quantitation of the Western blot and zymogram (mean + 
SEM, n=4, * p<.05).  Gelatin zymography from fresh aortic valve leaflets for MMP-









Figure 4.2: Cathepsin L is present in all layers of the aortic valve leaflet.  Pig 
valve aortic leaflets that were exposed to cyclic pressure (170 mm Hg at 1.17 Hz) or 
static controls for 48 hr were frozen sectioned and immunostained with the cathepsin 
L antibody and counterstained with hematoxylin and eosin.  V indicates the 
ventricular side of the leaflets.  Light microscopic images were taken using a 4X 
objective.  Cathepsin L expression is indicated by the brown staining and arrows. 




Aortic valve leaflets express MMP-2 more in the ventricularis than the 
spongiosa.  MMP-2 expression was stronger in the ventricularis region of the aortic 
valve leaflets under atmospheric (Figure 4.3A) and cyclic pressure (Figure 4.3B) 
conditions.  MMP-9 was distributed similarly (Figure 4.3C, D). 
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Figure 4.3: MMP-2 and MMP-9 immunohistochemistry on aortic valves under 
static conditions and cyclic pressure.  Pig valve aortic leaflets that were exposed to 
cyclic pressure (170 mm Hg at 1.17 Hz) or static controls for 48 hr were paraffin 
embedded, and immunostained with the MMP-2 (A, B) or MMP-9 (C, D) antibodies.  
V indicates the ventricular side of the leaflets, and arrows indicate positive staining.  
MMP-2 staining is stronger in the ventricularis than other layers.  Shown are 
representative light microscopic images from 4 different leaflets each.   
Steady shear stress inhibits cathepsin L protein amount and activity.   
Next, we examined the effect of laminar shear stress on cathepsin activity and 
cathepsin L protein expression.  Exposure to 25 dynes/cm2 shear stress for 48 hours 
decreased cathepsin L protein amount as seen by Western blot of porcine aortic heart 
valves (Figure 4.4A).  In addition, shear stress significantly inhibited cathepsin 
activity as determined by two independent assays, gelatin zymography (Figure 4.4B) 
and cathepsin peptide substrate assay (Figure 4.4C).  The cathepsin-specific activity 
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was demonstrated by the complete inhibition of gelatin proteolysis by E-64 (Figure 
4.4B), and the inhibition of shear-induced cathepsin L-like activity is further 
supported by the synthetic substrate Z-FR-AMC, which has a preferential specificity 
toward cathepsin L (Figure 4.4C).  In contrast to this, shear stress increased the 
activity of MMP2/9 in the aortic valve leaflets as seen by gelatin zymography (Figure 
4.4D).   
 
Figure 4.4: Steady shear stress decreases cathepsin activity and cathepsin L 
protein expression but increases MMP-2 activity in aortic valve leaflets.  Porcine 
aortic valve leaflets that were exposed to steady laminar shear stress (25 dyne/cm2) or 
no flow (as static control) for 48 hrs were frozen and lysed.  Equal aliquots of lysates 
were analyzed by Western blot with cathepsin L antibody (A) and gelatin 
zymography for cathepsins (B) or for MMPs (D). Representative blots (A) and 
zymography (B) in the absence (upper) or presence (lower) of E-64, the cathepsin 
inhibitor, are shown.   The bar graph is the densitometric analysis of Western blots or 
zymography (mean±SEM, n=4, *p<.05). In C, lysates were used to determine 
cathepsin activity using the synthetic peptide (Z-FR-AMC) substrate (mean±SEM, 
n=4, *p<.05).   
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 We further examined in which area of the valve leaflet cathepsin L expression 
was affected by laminar shear by immunohistochemical staining with the cathepsin L 
antibody.  As shown in Figure 4.5A, cathepsin L was diffuse in the leaflet under static 
culture but stains stronger in the ventricularis after exposure to steady laminar shear 
stress (Figure 4.5B). Overall, MMP-2 and -9 staining in the leaflets showed no 
remarkable differences between control and shear groups, but there was stronger 
signal in the ventricularis region compared to the spongiosa (Figure 4.6A-D). 
 
Figure 4.5: Cathepsin L immunohistochemistry in response to shear stress.  
Cathepsin L immunohistochemistry staining in leaflets exposed to shear stress was 
carried out as described in Figure 4.2. V- indicates the ventricular side of the leaflets, 
and arrows indicate positive staining. Note that the distribution of cathepsin L was 
different between shear and control, too.  Under shear, majority of the staining was 
found in the ventricularis; while in the control, cathepsin L was diffusely distributed 




Figure 4.6: MMP-2/9 immunohistochemistry in response to shear stress.  MMP-
2/9 immunohistochemistry staining in leaflets exposed to shear stress was carried out 
as described in Figure 2. V- indicates the ventricular side of the leaflets, and arrows 
indicate positive staining. Under control and shear conditions, strong staining was 
found in the ventricularis (n=5).   
Discussion 
We have shown in the present study that hypertensive pressure caused a 
significant reduction in cathepsin L activity and a minor reduction in MMP2/9 
activity in porcine aortic valve leaflets, while steady laminar shear stress decreased 
cathepsin activity and cathepsin L expression but increased MMP2/9 activity; our 
previous results showed significant increases in collagen content under identical 
mechanical conditions (7, 8).  It appears that there is an inverse relationship between 
collagen synthesis and cathepsin activity under the stimulation of hypertensive 
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pressure or steady shear stress. Since the function of cathepsins are to degrade 
collagen, the observed higher collagen content under hypertensive pressure/shear 
stress conditions is likely due, in part, to a downregulation of the collagenolytic 
activities. The net collagen amount in the valve tissue is determined by a dynamic 
balance between new synthesis and degradation by collagenases such as cathepsins 
and MMPs.   
The novel finding of the current study is that the cathepsins, collagenolytic 
proteases, are regulated by mechanical factors. Both, an increase in synthesis and a 
decrease in degradation will lead to higher total collagen content in the leaflet tissue. 
Previously, we showed that cathepsin L is inhibited by steady shear stress in aortic 
endothelial cells (15), but here, for the first time, we report that cathepsin L 
expression is regulated by cyclic pressure and shear stress and appears to correlate 
with the ECM renewal/remodeling in normal heart valve tissue. Previous studies have 
indicated the involvement of cathepsin K and S in myxomatous mitral valves (18), 
but so far there is no report on cathepsins in normal healthy heart valves. In addition 
to cathepsin L, we also studied MMP-2 and MMP-9 protein content and gelatinase 
activity because of their well-known role in ECM remodeling (27, 28) as well as in 
valve pathology (23, 29-31).  We saw similar changes of MMP-2 and -9 induced by 
hypertensive pressure but opposite results with steady shear stress in the valve tissue.  
These two protease families may play different roles in ECM remodeling under shear 
stress; for example, one family could be responsible for degradation of the old 
components while the other is important in organization of the newly synthesized 
matrix.  
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In contrast to the shear effect, cyclic pressure inhibited cathepsin L activity 
without altering its protein level. This raises a possibility that cyclic pressure may 
regulate cathepsin activity either by controlling the cathepsin inhibitors such as 
cystatin C, or by directly inhibiting the cathepsin L activity through post-translational 
modifications. 
The IHC staining results showed that cathepsin L was expressed throughout 
the layers of the valve leaflets, even the interstitial cells, but the MMPs showed 
stronger staining in the ventricularis over the spongiosa.  Immortalized endothelial 
cells increase MMP-2/9 activity by steady shear stress compared to static culture (32) 
which could be the case here in our ex vivo valvular model leading to increased 
MMP-2/9 activity by shear stress.  Since our IHC for cathepsin L and MMP-2/9 was 
not conclusive as far as specific protein amount, we did not see a difference in cell 
type expression of these proteases, we used the Western blotting and zymography 
data as quantitative indicators of protease activity in the total porcine aortic valve 
exposed to the various mechanical conditions.   
 The importance of flow characteristics in tissue remodeling and disease 
progression has been studied by both engineers and pathologists. The aortic valve 
experiences a complex hemodynamic environment. Three distinct flow regions exist 
in the aortic valve: the aortic wall of the sinus of valsalva characterized with low, 
disturbed flow; the side of the leaflets facing the aorta with low shear, laminar flow 
and the side facing the ventricle with high shear, laminar flow (33).  
Implications: The significance of these results is two-fold. First, it helps to 
improve understanding of the acute responses of the AV to hypertensive pressure.  
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Recent clinical retrospective studies indicate that the hypertension is a risk factor for 
valvular disease such as aortic valve stenosis. However, it is not yet clear how 
hypertensive pressure is involved in this pathophysiology, especially during the early 
stages of the disease. Results from this study showed that hypertensive pressure could 
induce changes in valve matrix synthesis within 48 hrs, indicating that valvular 
matrix remodeling may contribute to the development of aortic valve stenosis in 
hypertensive patients.  The involvement of cathepsins in these processes implicates 
this protease family as a potential drug target which might slow down the remodeling 
process induced by abnormal mechanical stimuli. Additionally, these results offer 
improved strategies for development of tissue engineered heart valves.  A tissue 
engineered heart valve created with biodegradable scaffolds or ECM need to have 
controlled degradation.  Our results suggest that culture under flow can reduce 
cathepsin mediated proteolysis which could extend the life of the scaffold in the 
construct. 
In summary, this study, for the first time, has shown that cathepsin L, MMP-2, 
and MMP-9 may be involved in valvular ECM remodeling induced by hypertensive 
pressure, while cathepsin L may be contributing to remodeling under regions of 
stagnant flow.  
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OSCILLATORY SHEAR STRESS AND LAMINAR SHEAR STRESS 




Cathepsin K, first identified in osteoclasts, (1-4) is known as one of the potent 
mammalian elastases (4-6) and is capable of cleaving mature, insoluble elastin (4-6) as 
found in the arterial wall.  However, cathepsin K expression and its role in atherosclerosis 
and abdominal aortic aneurysmal development have not received much attention until 
recently.  Cathepsins K, L, and S, potent elastinolytic proteases, have been identified in 
atherosclerotic plaques (7, 8) and in neointima following balloon angioplasty (9).  In 
addition, cathepsin activity is increased in abdominal aortic aneurysms (AAA) (7, 10).    
Smooth muscle cell expression of cathepsin K has been studied, particularly with regard 
to cytokine induction (8), while endothelial cell expression of cathepsin K is fairly 
limited to immunostaining in human plaques  (11).  Lack of cathepsin K in ApoE 
deficient mice fed a high fat diet reduced the number and size of atherosclerotic lesions, 
increased collagen content, and decreased breaks in the elastic lamina (11). 
The importance of shear stress in vascular biology and pathophysiology has been 
highlighted by the focal development patterns of atherosclerosis in hemodynamically 
defined regions. For example, the regions of branched and curved arteries exposed to 
disturbed flow conditions including oscillatory and low mean shear stresses (OS) 
correspond to athero-prone areas.  In contrast, straight arteries exposed to pulsatile, high 
levels of laminar shear stress (LS) are relatively well protected from atherosclerotic 
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plaque development (12).  Several human and animal studies have demonstrated that 
atherosclerotic lesions and aneurisms of the abdominal aorta occur in the regions where 
they are exposed to unstable flow conditions such as flow reversal, low mean wall shear 
stress and high oscillatory shear index (13-18). 
Our previous findings show that another member, cathepsin L, is inhibited by 
unidirectional laminar shear stress leading to reduced gelatinase and elastase activity 
(19).  Therefore, we examined the hypothesis that exposure of endothelial cells to OS and 
LS will regulate cathepsin K expression and activity leading to changes in gelatinase and 
elastase activity.  Our findings show that OS induces cathepsin K expression and activity 
in comparison to LS, which inhibits this enzyme in endothelial cells suggesting a role for 
cathepsin K at sites of disturbed flow and involvement in pathological vascular 




Mouse Aortic Endothelial cells (MAEC) culture and shear stress studies.  Endothelial 
cells obtained from the thoracic aortas of C57/BL6 control were isolated and cultured in 
growth medium growth medium [DMEM containing 20% fetal bovine serum (FBS), 100 
µg/ml endothelial cell growth supplement (ECGS, Sigma) and 2.5 U/ml heparin)] as 
described previously (20) and used between passages 7-10. Confluent endothelial 
monolayers grown in 100 mm tissue culture dishes were exposed to an arterial level of 
uni-directional LS (15 dyn/cm2) or OS with directional changes of flow at 1 Hz cycle (± 5 
dyn/cm2) by rotating a Teflon cone (0.5° cone angle) as described previously by us (21) 
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One hour prior to shear, the monolayers were washed and changed to 10 ml of fresh shear 
medium (the growth medium without serum). 
 
Quantitative Real-time PCR.  Following shear exposure, cells were washed with ice-
cold PBS.  Real-time PCR for Cathepsin K was carried out as previously described (22). 
Briefly, 4 µg of total RNA was reverse-transcribed using random primers and a 
Superscript-II kit (Invitrogen) to synthesize first-strand cDNA. The cDNA was purified 
using a microbiospin 30 column (Bio-Rad) in Tris buffer and stored at –20 °C until used. 
The cDNA was amplified using a LightCycler (Roche Applied Science) RT-PCR 
machine. The mRNA copy numbers were determined based on standard curves generated 
with murine Cathepsin K and 18 S templates. The 18 S primers (50 nM at 61 °C annealing 
temperature; Ambion) were used as an internal control for real-time PCR using a 
LightCycler and capillaries (Roche Applied Science), recombinant Taq polymerase 
(Invitrogen), and Taq start antibody (Clonetech). A quantitative RT-PCR using Cathepsin 
K primer pair (forward 5’-AAG TGG TTC AGA AGA TGA CGG GAC-3’ and reverse, 
5’-TCT TCA GAG TCA ATG CCT CCG TTC-3’) was carried out using an annealing 
temperature of 55°C and extension time of 7 s in the PCR buffer (20 mM Tris-Cl, pH 8.4, 
at 25 °C, 4mM MgCl2 to which was added 250 µg/ml bovine serum albumin, 200 µM 
deoxynucleotides) containing SYBR green (1:84,000 dilution), 0.05 unit/µl Taq DNA 
polymerase, and Taq Start antibody (1:100 dilution). 
 
Western blots. Following shear exposure, conditioned media were collected and 
normalized to 10 ml total with fresh serum free shear media if necessary, and 
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concentrated 20 to 30 fold with a spin concentrator (5 kDa molecular weight cutoff, 
Vivascience).  Cells were rinsed twice with phosphate buffered saline and then lysed with 
RIPA buffer.  Following modified Lowry protein assay, equal amounts of total protein 
were resolved by SDS-PAGE.  Protein was transferred to a polyvinyldifluoride 
membrane (Millipore), and probed with a mouse monoclonal anti-cathepsin K antibody 
(1:200, Calbiochem), anti-cathepsin L (1:500, R&D), anti-cathepsin S (1:1000, Santa 
Cruz), and anti-actin (1:1000, Santa Cruz) and a secondary antibody conjugated to 
alkaline phosphatase (Bio-Rad), which were detected by a chemiluminescence method 
(23). 
 
Transwell Assay. MAEC were grown to confluence on gelatin coated Transwell filters 
with pore size of 0.2 µm in growth medium.  Medium was replaced with serum free 
medium for eight hours.  Equal volumes were collected from apical and basal chambers, 
and proteins were precipitated with ice cold acetone and prepared for Western blotting as 
described above. 
  
Transfection of siRNA:  To knockdown mouse cathepsin K mRNAs, the annealed 
siRNA duplex [sense: 5’-GCA AGC ACU GGA UAA UUA A tt’, antisense: 5’ UUA 
AUU AUC CAG UGC UUG C- tt] (MWG Biotech) and nonsilencing duplex [sense: 5’- 
UUC UCC GAA CGU GUC ACG Utt, antisense: 5’- ACG UGA CAC GUU CGG AGA 
Att] (Qiagen) were obtained. Sub-confluent (75-80% confluency) MAEC were 
transfected at a final siRNA duplex concentration of 100 nM using Oligofectamine 
(Invitrogen) in serum free medium.  After 6 hrs, the medium was supplemented with FCS 
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(final 10% concentration) and cultured an additional 42 hrs prior to exposing the cells to 
OS, LS, or no flow conditions. 
 
Gelatinase and elastase assay.  Five µg/ml of BODIPY® fluorescein-conjugated DQ™ 
elastin or gelatin (Molecular Probes) in 5 ml of fresh serum-free DMEM was incubated 
with MAEC following exposure to OS, LS, or St for one day.  After an additional 24 
hours, aliquots (200 µl) of conditioned media were assayed with a fluorescence plate 
reader, in triplicate, with background fluorescence subtracted from the no-cell negative 
control at 485 nm excitation and 525 nm emission. 
 
JPM biotin labeling.  Media was collected after 24 hours exposure to OS, LS, or static 
conditions and centrifugally concentrated with a 5 kDa molecular weight cutoff 
(Vivascience).  Equal aliquots of protein were incubated in buffer containing 50 mM Na 
Acetate pH 4.2, 1 mM EDTA, 1% Triton, 3 mM DTT, with 20 µM of the biotinylated 
JPM probe at 37°C for 30 minutes prior to addition of Laemmli buffer, boiling, and 
separation by a 12.5% SDS-PAGE.  Proteins were transferred to PVDF membranes, and 
probed for biotin with the VectaStain Elite kit (Vector Labs) according to manufacturer’s 
instructions. 
 
Immunohistochemistry: Frozen sections of human coronary arteries from transplant 
patients were acquired and fixed in acetone.  After air drying and blocking for 30 minutes 
with 1% gelatin/PBS, the cathepsin K primary antibody (Calbiochem) was incubated in a 
1:20 dilution of 1% BSA/PBS for one hour followed by a PBS rinse then secondary 
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antibody incubation, conjugated to alkaline phosphatase, diluted in 1% BSA/PBS + 2% 
normal serum for 30 minutes.  Vector ABC kit (Vector) was used for color reaction 
according to manufacturer’s instructions.  Hematoxylin was used to counterstain.  
Negative control was incubated with 1% BSA/PBS in the absence of primary antibody.  
Slides were viewed with a microscope to visualize color reaction, and then viewed under 
an inverted fluorescent microscope with FITC filter and laser excitation to view elastin 
auto-fluorescence. 
 
Statistical Analysis. Student’s unpaired t-test was used to establish significance between 




LS decreases cathepsin K mRNA and protein expression in endothelial cells 
compared to OS. 
We initially found that cathepsin K is a mechanosensitive gene by DNA 
microarray analysis done on MAEC exposed to 24 hours of OS, LS, or no flow (static) 
conditions and found that OS increases cathepsin K mRNA levels by 2.5 fold over St and 
LS (Figure 5.1A).  To verify this finding, we employed quantitative real time PCR assay 
using 18S as an internal control.  MAEC exposed to OS showed a 2.4- and 1.7-fold 
higher cathepsin K mRNA levels than those exposed to static and LS, respectively 
(Figure 5.1B).  Cathepsin K mRNA levels between static and LS were not significantly 
different.  
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 Steady laminar shear stress also significantly decreased pro- and mature cathepsin 
K protein levels in the cell lysate by 55% and 80%, respectively, after 24 hours exposure 
to OS, LS, or St control (Figure 5.1C).  However, MAEC cultured under no flow 
conditions contained more twice as much cathepsin K as OS stimulated cells.   
 
 
Figure 5.1.  OS and LS differentially regulate cathepsin K mRNA and protein 
expression in endothelial cells.  Confluent MAEC were exposed to Static (St), 
oscillatory shear (OS), or laminar shear stress (LS) for 1 day.  Following shear, total 
RNA from cell lysates for real time PCR were prepared or cells were lysed for Western 
blot.  The bar graph in Panel A shows cathepsin K mRNA levels normalized against the 
18S and expressed as fold change of static control values (mean ± SEM, * p<0.05, n= 5 
to 7).  Panel B shows a representative Western blot using an equal amount of protein 
from cell lysates and probed with an antibody to cathepsin L and a β actin antibody as an 
internal control.  Densitometric quantification is shown in the bar graphs (mean ± SEM, 
n=4, *p< .05).  Panel C is a representative blot from 2 independent experiments using 
MAEC exposed to static culture, ± 5 dyn/cm2 OS, 5 dyn/cm2 LS, and 15 dyn/cm2 LS. 
 
Low and oscillatory shear stresses are found at sites of disturbed flow leading to 
atherosclerosis and AAA development, so to determine whether it was the direction or 
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the magnitude of the shear stress that was regulating cathepsin K protein levels, we 
exposed MAEC to lower levels (5 dynes/cm2) of steady laminar shear stress equal in 
magnitude to the OS profile, but in one direction.  From figure 5.1C, the lower magnitude 
of LS still inhibits MAEC expression of cathepsin K by 35% for the proform and 74% for 
the mature form illustrating the importance of unidirectional flow suppressing cathepsin 
expression.  Furthermore, higher magnitude of shear stress reduced the level even more 
(49% for proform and 82% for the mature form) suggesting that the magnitude of shear 
stress is inversely related to cathepsin K expression in MAEC. 
 
MAEC secrete cathepsin K in a shear regulated manner and preferentially in the 
basal direction.  
Since cathepsin K is a secreted protein in osteoclasts (4), we examined the protein 
levels in the conditioned media of MAEC exposed to OS, LS and no flow conditions for 
2 to 24 hrs.  The pro-cathepsin K protein (37 kDa) secreted into the conditioned media in 
a time-dependent manner was readily detected in cells exposed to static and OS groups 
(Figure 5.2A).  However, pro-cathepsin K protein level was extremely low in the 
conditioned media of LS exposed cells.  After 1 day of LS exposure, pro-cathepsin K 
level in LS group was 21% of OS group (Figure 2A).  Interestingly, the mature cathepsin 
K form (25 kDa) was detectable only in MAEC exposed to OS, but not in those of static 





Figure 5.2.  MAEC secrete cathepsin K in a shear regulated manner and 
preferentially in the basal direction.  A) Confluent MAEC were exposed to Static (St), 
oscillatory shear (OS), or laminar shear stress (LS) for 2 to 24 hr.  Recombinant cathepsin 
K (rCath K) was used as a positive control.  The procathepsin K band (37 kDa) was 
densitometrically quantified and presented as % of 24 hr static control as shown in the 
bar graph (mean ± SEM, * p<0.05, n= 2 to 5).  Note that only MAEC exposed to OS 
show a mature, active cathepsin K band (25 kDa) in their conditioned media. B) MAEC 
were grown to confluence on Transwell filter with 0.2 µm pore size and media was 
sampled from the apical and basal chambers, then equal aliquots of protein were used for 
Western blot (mean ± SEM, * p<0.05, n= 5). 
 
Endothelial cells line the blood vessel wall and are capable of secreting proteins 
apically, into the bloodstream, or basally, into the vessel wall.  For cathepsin K to 
function to remodel the vessel wall, we hypothesized that endothelial cells secrete it in 
the basal direction.  We tested this hypothesis using a Transwell filter assay.  MAECs 
were grown to confluence on the 0.2 µm filter to allow for proteins to pass, but not cells.  
After an 8 hour incubation in serum free medium, the conditioned medium was collected 
and assayed for cathepsin K protein.  It was clear that MAEC preferentially secrete 
procathepsin K in the basal direction, although there is apical release of the protein 
(Figure 5.2B).  These MAEC were cultured under static conditions in which mature 
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cathepsin K is not detected by Western blot.  We verified that cathepsin K was not 
moving through the endothelial cell layer by addition of mature cathepsin K to the apical 
or basal chamber, but it was not detected in the opposite chamber after the period of 
incubation (data not shown).   
 
Cathepsin K siRNA knocks down cathepsin K protein and activity.  
We decided to use a siRNA approach to determine the specific contribution of 
cathepsin K to extracellular matrix proteolytic activity which we have previously shown 
to be increased by OS and to be decreased by LS and to be cathepsin dependent (19), but 
it was important to first validate the specificity of the siRNA towards cathepsin K over 
cathepsins L and S, the other highly elastinolytic and collagenolytic family members.  
Treatment of MAEC with cathepsin K siRNA significantly knocked down cathepsin K 
protein expression as shown in Western blots of the cell lysates (Figure 5.3A) and the 
conditioned media (Figure 5.3B).  In contrast, a non-silencing siRNA control had no 
effect on the protein levels.  Transfection of the siRNA does not affect the reduction in 
cathepsin K protein by LS.  It is also evident that cathepsin S is downregulated by LS in a 





Figure 5.3.  Cathepsin K siRNA knocks down cathepsin K protein and activity.  Sub-
confluent MAECs were transfected with cathepsin K specific siRNA (100 nM) or 
nonsilencing RNA (non siRNA) 24 hours prior to shear exposure.  Transfected cells were 
then exposed to OS, LS, or static conditions for 1 day.  Cathepsin K protein knockdown 
by cathepsin K siRNA was confirmed by Western blot using cell lysates (A) and 
conditioned media (B).  Samples were probed with antibodies to cathepsins K, L, and S, 
and a β actin antibody as an internal control.  
 
By Western blot, procathepsin K was highly detected while the mature form was 
faintly detected under OS (Figure 5.2A); the mature form is responsible for proteolytic 
activity.  We employed the use of the biotinylated, activity based probe JPM to detect any 
active, mature cathepsin K secreted into the conditioned media in response to OS.  The 
mature cathepsin K band migrates similarly to other cathepsin family members in this 
assay, and since the biotinylated probe detects many active cathepsins, we also 
transfected cells with cathepsin K siRNA to compare which bands contained the 
cathepsin K signal.  Recombinant cathepsin K labeled with the biotinylated JPM was also 
used as a positive control and as an aid in locating mature cathepsin K secreted by the 
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MAEC in response to shear.  Figure 5.3C shows that there is an increase in the band near 
the cathepsin K positive control in response to OS which confirms our findings from 
figure 5.2A.  Confirmation that this is the cathepsin K band is seen in the reduction of its 
intensity in the conditioned media collected from MAEC transfected with cathepsin K 
siRNA suggesting that OS does increase the level of mature, active cathepsin K in the 
extracellular environment where it may be capable of degrading the extracellular matrix 
comprising the blood vessel wall. 
 
Cathepsin K contributes to endothelial cell elastase activity, and Cathepsin K siRNA 
knocks down shear mediated gelatinase activity. 
From the above result, it was clear that MAEC were producing active cathepsin K 
in response to OS, and we had previously shown that OS increases elastase and gelatinase 
activity of MAEC compared to LS, with cathepsins contributing greatly.  Taken together, 
we hypothesized that cathepsin K contributed to this extracellular matrix proteolytic 
activity, the extent of which was unknown.  To test this hypothesis and determine 
cathepsin K’s involvement in this shear regulated activity, cathepsin K siRNA treatment 
of MAEC was used in conjunction with the fluorescent elastase and gelatinase assays.  
Cathepsin K knockdown with siRNA reduced MAEC elastase activity by 30% in 
response to OS and St conditions (Figure 5.4A).  As expected from previous findings, LS 
significantly reduces the elastase activity in the nonsilencing controls compared to OS 
and St, but interestingly, there was no further reduction when cathepsin K was knocked 
down, presumably because LS reduced MAEC expression of cathepsin K leaving only a 
small amount of protein to knockdown further. 
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Figure 5.4.  Cathepsin K contributes to endothelial cell elastase activity, and 
Cathepsin K siRNA knocks down shear mediated gelatinase activity.  MAEC were 
transfected with cathepsin K specific siRNA (100 nM) or non-silencing RNA (non 
siRNA) control 48 hours prior to shear.  Transfected cells were then exposed to OS, LS, 
or static conditions for 1 day.  Following shear, BODIPY -gelatin or -elastin were added 
to intact cells and incubated overnight in fresh media.  Elastase (A) and gelatinase (B) 
activities were measured as an increase in fluorescence intensity.  The bar graphs show % 
of static control values (mean ± SEM, * p<0.05, n= 3 to 4).   
 
  Cathepsin K knockdown affected gelatinase activity slightly differently.  LS 
reduced this activity by almost 50% in the nonsilencing controls, and again, there was no 
further reduction of gelatinase activity after knocking down cathepsin K (Figure 5.4B).  
This again confirms that LS inhibits cathepsin K to such low levels in MAEC that further 
knockdown does not produce significant changes.  It does significantly reduce gelatinase 
activity of MAEC exposed to OS by 43% and of Static by a small but significant 11%.   
 
Endothelium overlying disrupted IEL expresses cathepsin K.  To provide 
physiological evidence for the role of cathepsin K in arterial remodeling, we performed 
tissue staining of minimally diseased coronary arteries vs. diseased arteries using an anti-
cathepsin K antibody.  We found stronger staining of cathepsin K over disrupted IEL 
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using elastin auto fluorescence.  This double blind grading of endothelial cell cathepsin K 
staining intensity and disrupted IEL had a correlation of .74 (Figure 5.5). 
 
Figure 5.5.  Endothelium overlying disrupted IEL expresses cathepsin K.  
Immunohistochemical staining of human coronary arteries for cathepsin K in minimally 
diseased (A) and atherosclerotic (B) regions.  Autofluorescence of elastic laminae reveals 
breaks in the structures.  (C) Double blind grading of endothelial cell staining intensity 
and internal elastic laminar loss of integrity. 
 
Discussion 
The novel findings of this study are that (1) OS increases endothelial cell 
cathepsin K mRNA and protein levels as well as activity over that of LS and (2) OS 
increases endothelial cell secretion of mature cathepsin K over St and LS conditions (3) 
endothelial cells show a basal preference for secretion of cathepsin K (4) shear stress 
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regulation of cathepsin K activity moderates endothelial cell gelatinase and elastase 
activity; and (5) endothelial cells in human coronary arteries overlying disrupted IEL 
express cathepsin K.  These results support our earlier finding that another member of the 
cathepsin family is regulated by shear stress. 
Here, we showed that OS upregulates cathepsin K mRNA level by 2.4 fold over 
static control (Figure 5.1A) but there is more protein in the MAEC cultured under static 
conditions (Figure 5.1B) which suggests that there could be some post-transcriptional 
regulation of cathepsin K mRNA.  However, it is also likely that since cathepsin K is 
activated by OS (as shown in Figure 5.2A and 5.3C) then the active protease could be 
capable of degrading itself leading to a lower steady state level of the enzyme in the cell; 
other cathepsins are activated by OS as well (19) and are responsible for protein turnover 
inside of the cell.  Cathepsin K has been shown to also autolytically activate itself by 
cleaving its own propeptide (24).  Once active, mature cathepsin K is present, then those 
molecules are capable of cleaving the propeptides off of others in solution (25).   
Figure 5.2A shows that mature cathepsin K (25 kDa) is detectable by Western 
blot extracellularly only from those cells that were exposed to OS which seems to 
account for the greater amount of active cathepsin K detected with the activity based 
probe in figure 5.3C.  It was interesting to note that mature and active form of cathepsin 
K was observed only in media from OS exposed cells, while the level of pro-cathepsin K 
was similar between the static and OS group.  This suggests that OS may be involved in 
stimulating conversion of the pro-form to the mature form, but the underlying 
mechanisms are not clear.  Knockdown of cathepsin K with siRNA significantly inhibited 
gelatinase and elastase activity of the static and OS treated cells, but not that of the LS 
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group (Figure 5.4A, B).  Once again, we refer back to the activation of cathepsin K by 
OS (Figure 5.2A, 5.3C) and the greatest reduction in matrix proteolytic activity seen with 
gelatinase activity (Figure 5.4A).  Cathepsin K is a powerful collagenase, capable of 
cleaving triple helical Type I collagen both at the telopeptides and intra-helically, a 
characteristic unique to this enzyme (6).   Since gelatin is denatured collagen, we accept 
that cathepsin K may have more of an effect on the turnover of that substrate.  Li et al 
have reported that binding of glycosaminoglycans (GAGs) regulate cathepsin K activity 
towards type I collagen; chondroitin sulfate increases cathepsin K collagenolytic activity 
by forming multimeric complexes while dermatan sulfate, heparin sulfate, and heparin all 
inhibit this activity and compete for the active site of cathepsin K (26).  Elastase activity 
was not examined so it is unknown at present if it is altered by GAG binding.  These 
alternative factors that regulate cathepsin K extracellular matrix proteolytic activity could 
serve as additional protectants against uncontrolled degradation after release of cathepsin 
K in disease conditions, such as oscillatory shear stress and atherosclerosis.  An 
investigation of how shear stress regulates endothelial cell GAG production could 
provide some insight into these regulations of cathepsin K activity. 
Endothelial cells are polarized cells with an apical surface exposed to the blood 
flowing through the lumen of the vessel and a basal portion that sits on basement 
membrane and the other layers of the vessel wall.  This polarity has been shown to be 
important in different experiments including a previous study in our lab showing how 
caveolae form on the apical side in response to shear stress (27).  The current study‘s 
report that cathepsin K is secreted preferentially out of the basal surface of the cell gives 
a context for its secretion into the vessel wall and suggests that shear stress can regulate 
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cathepsin K presence and activity in vascular remodeling.  Cathepsin K has been co-
localized with endothelial cells in human atherosclerotic samples as well as with smooth 
muscle cells (SMCs) and macrophages (11).  Endothelial cell contribution of cathepsin K 
may work mainly in the initial phases of atherosclerosis when the IEL is first degraded to 
signal SMC migration into the subintimal space, and it could be important in later stages 
of the plaque leading to plaque rupture.  In fact, transient expression of cathepsin K in 
human plaques has been demonstrated (11).  Many plaques rupture at the shoulder 
regions for a mechanical and biological reasons (28, 29), and the endothelium is still 
present at these areas.  Also, fibrous plaques are composed mainly of collagen, a prime 
substrate for cathepsin K hydrolysis.  Local secretion of cathepsin K in response to OS at 
these sites could be the metaphoric “straw” that breaks the plaque.  Even procathepsin K 
secreted into the subintimal space can be activated as macrophages in the vessel wall 
locally acidify the environment after coming into contact with elastin (30) and cathepsin 
K can autolytically activate itself under acidic conditions (25). Atherosclerotic plaque 
environments also display pH heterogeneity with lower pH found near large lipid pools, 
presumably because of the greater presence of lipid-laden macrophages (31).  Evidence 
of cathepsin K at the site of plaque rupture has already been demonstrated in human 
samples, and the absence of cathepsin K in mice increased plaque collagen content but 
reduced plaque progression(11).   
Our result of tissue staining of cathepsin K in the endothelium of human coronary 
arteries increasing with damage to the IEL (Figure 5.5) opens the possibility of using 
endothelial cell cathepsin K clinically as a biomarker for atherosclerosis.  Transient 
expression of cathepsin K at different stages of the atherosclerotic development has been 
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shown in humans (11); biomarkers for endothelial cell cathepsin K could be used as 
predictors of sites of plaque rupture.  The tissue staining correlation also supports our 
hypothesis that this enzyme works to breakdown structures of the arterial wall during 
plaque formation.  Elastases span different classes of proteases that must be capable of 
hydrolyzing mature, insoluble elastin.  Serine proteases, MMPs, and cysteine proteases 
all have members that are elastinolytic, but the serine proteases and MMPs have been the 
focus of attention as arterial elastinolytic enzymes.  Recent studies, however, have shown 
the important role of cathepsins and their inhibitor cystatin C in elastin degradation and 
atherosclerosis development.  Sukhova et al (32, 33) demonstrated that mice deficient in 
cathepsin S in LDL receptor-null mice show decreased internal elastic lamina 
fragmentation and reduction in atherosclerosis, while mice deficient for the inhibitor, 
cystatin C, had increased IEL fragmentation.  With respect to this, we have previously 
showed that cathepsin L gelatinase and elastase activity is also regulated by shear stress 
in endothelial cells (19), however, this current study is the first to show that shear stress 
regulates cathepsin K in endothelial cells as well.    
Arteries respond to changes in blood flow to maintain healthy levels of wall shear 
stress, and this process involves more than vasodilation and vasoconstriction, but it also 
includes the actual degradation and remodeling of the structures of the vessel wall in an 
endothelial cell-dependent manner.  Low blood flow conditions following angioplasty 
causes decreased lumen size due to inward remodeling of the vessel (34), while large 
increases in blood flow can increase the outward remodeling of the vessel (35).  Flow 
dependent arterial remodeling has been shown to be endothelium-dependent (36).  
Increases in blood flow during development of the vasculature or after surgically creating 
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an arterio-venous fistula cause remodeling of the internal elastic lamina (37). Taken 
together with the current findings, we suggest that mechanosensitive regulation of 
cathepsins and elastase and gelatinase activities play a role in the flow-dependent 
vascular remodeling. 
Our study provides insight into a potential mechanism by which the vascular 
structures and the internal elastic lamina can be degraded under disturbed flow 
conditions.  Based on our findings, we propose that OS increases cathepsin K expression 
and activity in endothelial cells, which, in turn stimulates gelatinase and elastase activity.  
The increased elastase activity then degrades elastins in the internal elastic lamina, 
resulting in their fragmentation, subsequent arterial wall remodeling, and atherosclerotic 
plaque development.  At later stages, this increased activity could contribute to fibrotic 
plaque rupture due to the powerful collagenase activity of cathepsin K.  In summary, we 
showed that cathepsin K is a mechanosensitive enzyme, which has a potential importance 
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CATHEPSIN LOCATIONS IN ENDOTHELIAL CELLS  
 
Introduction 
Cathepsins, traditionally referred to as the lysosomal cysteine proteases, are being 
discovered as having functions outside of these compartments.  Cathepsins S, K, and L 
are secreted by various cell types including macrophages (1-4), osteoclasts (5, 6), 
chondrocytes (7), and others.  Membrane bound cathepsin B is involved in angiogenesis 
(8) and tumor metastasis (9-11).  Cathepsin S binds to integrin alpha V beta 3 on vascular 
smooth muscle cells in response to cytokine stimulation (12).  Upon overexpression in 
tumor cells, cathepsin L aggregates in multivesicular bodies near the cell surface (13).   
Together, these support the concept that cathepsins may not be just in lysosomes 
in endothelial cells or that their location may change in response to shear stress.  
Caveolin-1 moves from the Golgi apparatus to the plasma membrane in response to LS 
(14), and several G proteins also change cellular location after induction of LS (15, 16).   
Since our findings are that oscillatory shear stress (OS) increases cathepsin K and 
S protein level and cathepsin L activity in mouse aortic endothelial cells (MAEC), we 
investigated the hypothesis that shear stress may regulate the intracellular locations of 
cathepsins using immunocytochemistry and cell fractionation.   
 
Methods 
Mouse Aortic Endothelial cells (MAEC) culture and shear stress studies.  Endothelial 
cells obtained from the thoracic aortas of C57/BL6 control were isolated and cultured in 
growth medium growth medium [DMEM containing 20% fetal bovine serum (FBS), 100 
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µg/ml endothelial cell growth supplement (ECGS, Sigma) and 2.5 U/ml heparin)] as 
described previously (17) and used between passages 7-10. Confluent endothelial 
monolayers grown in 100 mm tissue culture dishes were exposed to an arterial level of 
uni-directional LS (15 dyn/cm2) or OS with directional changes of flow at 1 Hz cycle (± 5 
dyn/cm2) by rotating a Teflon cone (0.5° cone angle) as described previously by us (18) 
One hour prior to shear, the monolayers were washed and changed to 10 ml of fresh shear 
medium (the growth medium without serum). 
 
Western blots. Following shear exposure, conditioned media were collected and 
normalized to 10 ml total with fresh serum free shear media if necessary, and 
concentrated 20 to 30 fold with a spin concentrator (5 kDa molecular weight cutoff, 
Vivascience).  Cells were rinsed twice with phosphate buffered saline and then lysed with 
RIPA buffer.  Following modified Lowry protein assay, equal amounts of total protein 
were resolved by SDS-PAGE.  Protein was transferred to a polyvinyldifluoride 
membrane (Millipore), and probed with a mouse monoclonal anti-cathepsin K antibody 
(1:200, Calbiochem), anti-eNOS (1:1000, Cell Signaling), and annexin II (1:1000, Santa 
Cruz) and a secondary antibody conjugated to alkaline phosphatase (Bio-Rad), which 
were detected by a chemiluminescence method (19). 
 
Immunocytochemistry.  Cells were rinsed with PBS, and fixed with 4% 
paraformaldehyde in PBS for 10 min at room temperature.  Cells were permeabilized 
with 0.2% Triton X-100 in PBS, and the fixative was quenched with 50 mM ammonium 
chloride.  Blocking buffer of 3% BSA in PBS was preincubated with the cells for an 
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hour, followed by overnight incubation with the primary antibody: anti-cathepsin L 
(1:100, Santa Cruz), anti-cathepsin S (1:100, Santa Cruz), anti-cathepsin K (1:50, 
Calbiochem), anti-GM 130 (1:100), anti-caveolin-1 (1:100), and rhodamine phalloidin 
(1:100).  Alexa 488 conjugated secondary antibodies were used to fluorescently label the 
primary antibody. Cells were rinsed with PBS then covered with Prolong anti-Fade Kit 
(Molecular Probes) and visualized on an epifluorescent microscope. 
 
Subcellular proteome extraction.  After shear exposure, cytosol was extracted with 10 
mM PIPES, 5 mM EDTA, pH 6.8, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, 0.01% 
(w/v) digitonin for 10 minutes.  Membrane/organelles were extracted with 10 mM PIPES, 
3 mM EDTA, pH 7.4, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, 0.5% (v/v) Triton 
X-100 for 30 minutes.  Nucleus was extracted in 10 mM PIPES, 0.5% deoxycholate, pH 
7.4, 1 mM MgCl2, 1% (v/v) Tween-40, 10 mM NaCl for 10 minutes.  After the stage of 
extraction, the plate was fixed with 4% paraformaldehyde and immunolabeled according 
to immunocytochemistry protocol described above. 
 
Plasma membrane cell fractionation.  Six plates were used for each shear condition.  
Cells were washed twice with ice-cold PBS.  Then they were washed twice with 5 ml 
buffer A (0.25 M sucrose, 1 mM EDTA, 20 mM Tricene, pH 7.8) and scraped in 3 ml 
buffer A.  Whole cell lysate aliquot was collected here.  Cells were pelleted by 
centrifugation for 5 minutes at 2500 x g and resuspended in 1 ml buffer A.  Cells were 
homogenized with a Wheaton tissue grinder with 20 strokes on ice.  Homogenate was 
transferred to a microfuge tube and centrifuged at 100 x g for 20 minutes to pellet 
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nucleus.  Post nuclear supernatant (PNS) was removed and stored on ice with re-
homogenization of the pellet and collection of PNS.  The PNS was layered over 30% 
Percoll in buffer A and centrifuged at 84,000 x g for 30 minutes.  The plasma membrane 
fraction was the visible band in the middle of the ultracentrifuge tube and was collected 
with a syringe. 
 
Versene wash.  Cells were washed with 0.53 mM EDTA in PBS to collect any proteins 
bound in a calcium dependent manner.  Proteins in the supernatant were precipitated in 
ice cold acetone to prepare for Western blot. 
 
Magic RedTM substrate. Assay was performed according to manufacturer’s instructions 
(Immunochemistry Technologies, LLC).  Briefly, the bi-substituted fluorophore cresyl 
violet is linked to two leucine-arginine (Z-LR)2 motifs rendering it nonfluorescent and 
susceptible to cathepsin K cleavage after which red fluorescence accumulates in the cell’s 
organelles.  Acridine orange (0.1% v/v) was used to label lysosomes and acidic 
organelles, and Hoechst was used for nuclear labeling (0.5% v/v).  Live cells were 
viewed under fluorescent microscope with the rhodamine filter for cresyl violet and 
acridine orange and the UV filter for Hoechst. 
 
Results 
Cathepsin L and S are in lysosomes. 
Immunostaining of MAEC exposed to OS, LS, or no flow control with cathepsin 
K, L, and S antibodies was done to find their intracellular location.  Cathepsins L and S 
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both showed a more lysosomal staining pattern as expected since these are the lysosomal 
family of cysteine proteases (Figure 6.1-6.2).  Capturing images under the same settings 
on the confocal microscope shows that there is a reduced signal in MAEC exposed to LS 
which supports our central hypothesis that LS inhibits endothelial cell production of 
cathepsins. 
 
Figure 6.1. Cathepsin L immunocytochemistry. 
 
Figure 6.2.  Cathepsin S immunocytochemistry. 
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Figure 6.3.  Cathepsin K immunocytochemistry. 
 
Cathepsin K positive labeling is in cytosol, nucleus, and cell membrane structures. 
Confluent MAEC were exposed to 24 hours OS, LS, or St and then fixed for 
immunostaining.  Cathepsin K was positive in the cytoplasm and in structures that were 
on the cell periphery with more found in MAEC exposed to OS (Figure 6.3).  
Preincubating the antibody with the blocking peptide failed to detect cathepsin K in these 
structures and in the cytoplasm showing that this is not a nonspecific signal (Figure 6.4).  
These structures appeared to be vesicular in nature which could have been a mechanism 
by which cathepsin K was being secreted by MAEC.    A Z-series of the endothelial cells 
revealed a hollow center in the structure (Figure 6.5).  Cathepsin K is known to be 
lysosomal, and our use of the Magic Red substrate, (Z-LR)2,  that enters the cell and 
fluoresces when cleaved by cathepsin K, shows lysosomal activity staining that matches 
with acridine orange, a molecule that localizes to acidic compartments such as lysosomes 
(Figure 6.6).   
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Figure 6.4.  Cathepsin K localizes to cell surface on membrane structures.  MAECs 
were exposed to static flow or LS, fixed, and incubated with anti-cathepsin K antibody 
(upper panels) or blocked anti-cathepsin K antibody blocked with the antigenic peptide 
(lower panels). 
 
Next, a subcellular proteome extraction was performed to stepwise remove 
layers/organelles from the cell to determine more specifically where cathepsin K was.  
The staining pattern changed at each step of the increased detergent strength.  After 
removing the cytosol and any loosely bound membrane structures with digitonin, the 
structures at the cell periphery were no longer visible (Figure 6.7).  Also, instead of the 
diffuse cytosolic staining seen before, cathepsin K could be seen in distinct vesicles 
inside of the EC in a pattern similar to lysosomes; again blocked antibody revealed that 
this staining was specific for cathepsin K.  Further detergent to remove the plasma 
membrane and organelles leaving cytoskeleton and lipid raft components still stain 
positively for cathepsin K, particular at the cell periphery and in the nucleus (Figure 
6.7B).  Removal of the nucleus at the next step still shows cathepsin K present with the 




Figure 6.5.  Cathepsin K localizes to hollow vesicular like structures on cell 
periphery.  Z-series captured with confocal microscope after immunolabeling with anti-





Figure 6.6.  Active cathepsin K intracellularly shows lysosomal staining pattern.  
Cell permeable cathepsin K substrate Z-(LR)2 was incubated with static cultured MAEC 
to visualize cathepsin K activity.  Acridine orange was used to label lysosomes, and 
Hoechst labeled cell nuclei. 
 
To show a specific co-localization of cathepsin K with known proteins that reside 
in these different cellular structures, we double labeled the cell caveolin-1, the central 
protein that comprises caveolae, specialized lipid raft structure, and with phalloidin to see 
filamentous actin. There appeared to be some co-localization of cathepsin K with 
caveolin-1 as seen by the faint yellow staining after overlaying the separate images 
(Figure 6.8).  There was yellow staining between cathepsin K and actin suggesting that 
cathepsin K is associating with cytoskeletal structures under OS, LS, and St conditions 












Figure 6.7.  Subcellular proteome extraction reveals different cathepsin K locations 
in the endothelial cell.  Cathepsin K staining with the antibody or blocked antibody 
reveal its location in MAEC.  Disappearance of the green staining after incubation with 












       Cathepsin K green                  Caveolae Red                           Merged image 
 
Figure 6.8.  Cathepsin K shows some co-localization with caveolin-1.  Subcellular 
proteome extraction and immunolabeling for cathepsin K and caveolin-1 after extraction 
of the cytosol (Static) and the membrane and organelle fractions (OS and LS).  Cathepsin 








Cathepsin K green                  Phalloidin Red                           Merged image 
 
 
Figure 6.9.  Cathepsin K shows co-localization with filamentous actin.  Subcellular 
proteome extraction and immunolabeling for cathepsin K and rhodamine phalloidin 
labeling after extraction of the cytosol and membrane and organelle fractions. Cathepsin 







Figure 6.10.  Cathepsin K is found in the cell membrane of MAEC.  After shear 
exposure, plasma membrane fraction of MAEC were isolated and run for Western blot.  




Using more specific techniques to detect cathepsin K in different areas of the cell, 
we performed cell fractionation to isolate the plasma membrane.  MAEC exposed to 24 
hours OS, LS, or no flow were lysed and fractioned on an Optiprep gradient.  Equal 
aliquots of protein from plasma membrane fractions were prepared for Western blotting 
and probed for cathepsin K.  In the whole cell lysate, we detected cathepsin K with the 
same regulation by shear as seen earlier; highest in static, then OS, and the least 
intracellular cathepsin K in those exposed to LS.  Interestingly, the plasma membrane 
fractions showed a change in relative amounts of cathepsin K with OS having the most 
amount of the enzyme in its plasma membrane fraction (Figure 6.10).  We also used a 
Versene wash on cells exposed to OS, LS, or no flow to determine if cathepsin K was 
bound to the surface by a calcium-dependent mechanism as annexin II is known to be 
(20).  There was no detectable cathepsin K in the Versene wash (Figure 6.11A) although 
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we did detect annexin II (Figure 6.11B) leading us to conclude that cathepsin K is not 
bound in a calcium dependent manner. 
 
Figure 6.11.  Cathepsin K is membrane bound, but not by a calcium dependent 
mechanism.  MAECs exposed to shear were lysed in buffer A and fractionated on an 
Optiprep gradient to collect plasma membrane, and equal amounts of protein were probed 
for cathepsin K.  MAECs exposed to shear were rinsed with a Versene wash (PBS + 0.53 
mM EDTA) and collected protein was probed for A) cathepsin K and B) annexin II. 
 
Discussion 
In combination, these studies show that cathepsins L and S have a predominantly 
lysosomal location within MAEC, but cathepsin K differs.  We have seen cathepsin K in 
the cytoplasm and associated with membrane and cytoskeletal structures both by 
immunolabeling and molecular biological techniques, and are still detecting its activity in 
acidic compartments inside of the cell.  We further show that cathepsin K shows some 
co-localization with caveolin-1, a marker of caveolae and also co-localizes with actin on 
the cell periphery by immunolabeling after subcellular proteomic extraction.  The first 
step of the extraction removes the loosely bound vesicular structures found in the control 
labeled cells. 
Cathepsin K is secreted by osteoclasts at the ruffled border where it serves to 
resorb bone in the acidic lacunae there (5, 6, 21, 22).  ECs secrete cathepsin K also, but 
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may also bind it to membrane for local proteolysis of basement membrane or other 
structures as needed in response to disturbed flow as found at sites of vascular 
remodeling leading to plaque formation and aneurysmal development. In in vivo studies, 
cathepsin K has been co-localized with ECs, SMCs, and macrophages in diseased vessels 
(23).  It was also found at sites of plaque rupture; ECs with cathepsin K bound at their 
cell surface at regions of disturbed flow could have activated cathepsin K, a powerful 
collagenase (24), where it is capable of degrading the collagen-filled fibrous cap and 
cause plaque rupture.  More work needs to be done to test this hypothesis. 
Cathepsin S has recently been shown to bind to integrin alpha V beta 3 on the 
smooth muscle cell surface resulting in a staining pattern similar to what we have seen 
with cathepsin K on the EC surface (12).  
It is possible that cathepsin K is associating with an integrin as well which places 
it at a prime location to participate in cell migration and proteolysis of ECM components.  
Integrin alpha V beta 3 is implicated by numerous studies in cell migration and 
angiogenesis and also binds MMP-2 at a non-RGD sequence that is still to be determined 
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UNIDIRECTIONAL LAMINAR SHEAR STRESS INCREASES 




Cathepsins B, K, L, and S are highly elastinolytic and collagenolytic cysteine 
proteases, capable of degrading the main structural components of the blood vessel wall 
(1-12).  Our work has shown that oscillatory shear stress (OS), such as that found in 
regions of disturbed flow where atherosclerotic plaques form, increases their activity and 
secretion from endothelial cells.  Conversely, unidirectional laminar shear stress (LS) 
inhibits their synthesis and activity in endothelial cells.  The acidic environment created 
by macrophage secretions in the plaque-forming, intimal region would provide an 
adequate environment for cathepsin activity although cathepsin S is still active at a 
neutral pH (1).  Release of these proteases into the intimal region of the vessel wall 
demands that an inhibitor be present to keep their activity at a minimum and to avoid a 
pathological condition; cystatin C is such an inhibitor. 
Cystatins are the group of inhibitors of lysosomal cysteine proteases, of which, 
cystatin C is the most powerful (1).  This 13 kDa protein is translated with a 26 amino 
acid signal peptide that targets it for secretion approximately an hour after post-
translational processing (2).  At this point its three-dimensional conformation forms a 
wedge shape that will block the substrate binding cleft of the cathepsin in a tight, 
reversible fashion (3) with an inhibition constant on the subnanomolar range (4).  In the 
context of atherosclerosis, its production and secretion has been studied in smooth muscle 
cells of blood vessel walls.  TGF-β, a cytokine present in blood vessel walls, induces an 
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increased secretion of cystatin C from smooth muscle cells although there is no 
detectable change in its mRNA levels (5).  Cystatin C has also been found in normal 
blood vessel tissue sections in the medial layer, but was absent in atherosclerotic sections 
(5, 6).  Mice null for cystatin C and Apolipoprotein E fed a high fat diet had increased 
elastic lamina degradation, increased smooth muscle cell and collagen content in the 
intimal region, and had expanded abdominal aortas providing evidence of the importance 
of this protease inhibitor in vivo in preservation of elastic structures in the arterial wall 
(7). Its production by endothelial cells remains elusive.  We show here that cystatin C is 
upregulated by endothelial cells in response to unidirectional laminar shear stress and 
downregulated under an oscillatory shear stress yet need to further investigate the 
molecular roles of cystatin C in atherosclerosis. 
From this data, we hypothesize that laminar shear stress induces the production 
and secretion of cystatin C by endothelial cells, and that these levels regulate and inhibit 
the vessel wall remodeling activities of cysteine proteases.  Alternatively, oscillatory 
shear stress signals endothelial cells to reduce either their production and/or secretion of 
cystatin C, while increasing cathepsin expression.  This results in a shift in the balance 
between the proteases and their inhibitor.  Eventually, this results in vessel wall 
remodeling and increased atherosclerotic plaque formation and growth. 
 
Methods 
Mouse Aortic Endothelial cells (MAEC) culture and shear stress studies.  MAEC 
obtained from the thoracic aortas of C57/BL6 mice were isolated, cultured in growth 
medium [Dulbecco’s modified Eagle’s medium (DMEM) containing 20% fetal bovine 
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serum (FBS), 100 µg/ml endothelial cell growth supplement (ECGS, Sigma) and 2.5 
U/ml heparin] as described (8), and used between passages 7-10. Confluent endothelial 
monolayers grown in 100-mm tissue culture dishes were exposed to an arterial level of 
uni-directional LS (15 dyn/cm2) or OS with directional changes of flow at 1 Hz cycle (± 5 
dyn/cm2) for 1 day by rotating a Teflon cone (0.5° cone angle) as described previously 
(8). One hour prior to shear, the monolayers were washed and changed to 10 ml of fresh 
shear medium (the growth medium without serum). 
 
Immunocytochemistry.  Cells were rinsed with PBS, and fixed with 4% 
paraformaldehyde in PBS for 10 min at room temperature.  Cells were permeabilized 
with 0.2% Triton X-100 in PBS, and the fixative was quenched with 50 mM ammonium 
chloride.  Blocking buffer of 3% BSA in PBS was preincubated with the cells for an 
hour, followed by overnight incubation with the primary antibody: anti-cystatin C (1:100, 
Upstate), anti-GM 130 (1:100), anti-vinculin (1:100, Calbiochem).  Alexa 488 (green) or 
Alexa 568 (red) conjugated secondary antibodies were used to fluorescently label the 
primary antibody. Cells were rinsed with PBS then covered with Prolong anti-Fade Kit 
(Molecular Probes) and visualized on an epifluorescent microscope. 
 
Immunohistochemistry: Frozen sections of human coronary arteries from transplant 
patients were acquired and fixed in acetone.  After air drying and blocking for 30 minutes 
with 1% gelatin/PBS, the cathepsin K primary antibody (Calbiochem) was incubated in a 
1:20 dilution of 1% BSA/PBS for one hour followed by a PBS rinse then secondary 
antibody incubation, conjugated to alkaline phosphatase, diluted in 1% BSA/PBS + 2% 
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normal serum for 30 minutes.  Vector ABC kit (Vector) was used for color reaction 
according to manufacturer’s instructions.  Hematoxylin was used to counterstain.  
Negative control was incubated with 1% BSA/PBS in the absence of primary antibody.  
Slides were viewed with a microscope to visualize color reaction, and then viewed under 
an inverted fluorescent microscope with FITC filter and laser excitation to view elastin 
auto-fluorescence. 
 
Microarray.  Total RNA was collected from MAEC after 24 hours of OS, LS, or Static 
culture and transcribed into cDNA, linearly amplified to cRNA, and hybridized to a 
Codelink DNA microarray.  Fluorescent labeling of bound cRNA was scanned for 
intensity. 
 
Enzyme Linked Immunosorbent Assay (ELISA). Assay was performed according to 
manufacturer’s instructions (Abcam).  Briefly, serum free conditioned media was 
collected after 24 hours OS, LS, and St and normalized to 10 ml, the pre-shear volume.  
Equal aliquots of 100 µl of conditioned media or cystatin C standards were dispensed 
into wells pre-coated with anti-cystatin C antibody.  Wells were washed thoroughly then 
incubated with horseradish peroxidase (HRP) labeled anti-cystatin C antibody.  After 
washing again, tetramethylbenzidine substrate was added to react with bound HRP and 
acidic stop solution (0.2 M H2SO4) was added to stop the yellow product forming.  This 
color change was measured with a spectrophotometer at 450 nm, and media samples were 
fit to the standard curve. 
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Plasmid transfection.  Full length cystatin C on a CMV Sport6 plasmid (ATCC) was 
transfected into subconfluent MAEC with Lipofectamine (InVitrogen) in serum free 
medium.  After 6 hours, the medium was supplemented with serum (final 10% 
concentration) and cultured an additional 42 hours prior to exposing the cells to OS, LS, 
or no flow conditions. 
 
Cathepsin activity assay.  Conditioned media were collected and concentrated.  Aliquots 
were added to a reaction mixture containing 100 mM acetate, pH 5.5, 2.5 mM EDTA, 2 
mM dithiothreitol, and 0.1% Brij 35.  Benzyloxycarbonyl-Gly-Pro-Arg-7-amino-4-
methylcoumarin (Z-GPR-AMC) (Biomol) was used as the substrate and added to attain a 
final concentration of 20 µM after the cathepsins were activated for two minutes at 37°C 
(9).  The reaction mixture was incubated at 37°C for 60 minutes, and AMC fluorescence 
intensity was determined with a fluorescence plate reader (excitation at 360 nm and 
emission at 460 nm). 
 
Western blots. Following shear exposure, conditioned media were collected and 
normalized to 10 ml total with fresh serum free shear media if necessary, and 
concentrated 20 to 30 fold with a spin concentrator (5 kDa molecular weight cutoff, 
Vivascience) or precipitated in five times the volume of ice cold acetone then centrifuged 
and resuspended at a 20 fold concentration of lysis buffer.  Cells were rinsed twice with 
phosphate buffered saline and then lysed with RIPA buffer.  Following modified Lowry 
protein assay, equal amounts of total protein were resolved by SDS-PAGE.  Protein was 
transferred to a polyvinyldifluoride membrane (Millipore), and probed with a rabbit 
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polyclonal anti-cystatin C antibody (1:1000, Upstate), anti-cathepsin K (1:250, 
Calbiochem) and a secondary antibody conjugated to alkaline phosphatase (Bio-Rad), 
which were detected by a chemiluminescence method (10). 
 
Results 
Laminar shear stress upregulates cystatin C mRNA and protein in mouse aortic 
endothelial cells.   
MAECs were grown to confluence and exposed to 24 hours of OS, LS, or St 
culture as described above.  Total RNA was collected and used for DNA microarray 
analysis on the Codelink array.  LS significantly increased cystatin C mRNA level by 2.5 
fold over OS and St as determined by the normalized fluorescent intensity on the array 
(Figure 7.1A).  Western blots were used to illustrate that the full protein is being 
expressed and secreted by the endothelial cells, in a manner that increases and decreases 
with mRNA levels.  Media was collected following a 24 hour shear period, and the 
proteins were precipitated with acetone.  After resuspension in sample buffer containing 
SDS and beta-mercaptoethanol, equal volumes were loaded into a 12.5% SDS-PAGE gel 
and blotted for cystatin C.  Cystatin C is largely secreted into the media during laminar 
shear stress, but at low levels under oscillatory shear (Figure 7.1B); it was undetectable in 
the cell lysate in any of the shear conditions.  ELISA performed on the conditioned media 




Figure 7.1.  LS upregulates cystatin C mRNA and secreted protein in MAEC.  
Confluent MAEC were exposed to 24 hours OS, LS, or St culture, and total RNA and 
conditioned media were collected.  A) Total RNA was transcribed into cDNA, linearly 
amplified to cRNA, and hybridized to a Codelink DNA microarray.  Fluorescent labeling 
of bound cRNA was scanned for intensity.  Bar graph shows median normalized values 
as fold change of Static control (n=3).  B) Conditioned media was precipitated with 
acetone and equal aliquots of protein or cystatin C positive control were prepared for 
Western blot with anti-cystatin C antibody.  C) Dilutions of conditioned media were used 
for ELISA assay according to manufacturer’s instructions and compared to a standard 
curve. 
 
LS correctly processes cystatin C through the secretory pathway but OS does not. 
To visualize cystatin C intracellularly, since it was not detected in the Western 
blot, we performed immunocytochemistry on the MAEC after exposure to shear and 
found that the intracellular location of cystatin C changed according to the type of shear 
stress.  Under OS and St culture, the cystatin C was diffuse in the cell and does not co-
localize with GM-130, the cis-Golgi marker (Figure 7.2).  However, there is a marked 
difference when the MAEC were exposed to LS; cystatin C is highly colocalizing with 
the Golgi apparatus, an organelle responsible for packaging secreted proteins.  This 




for secretion into the extracellular environment, but this mechanism is not turned on in 
response to OS or static culture where you see higher production and secretion of 
cathepsins. 
 
Figure 7.2.  LS correctly processes Cystatin C through secretory pathway but OS 
does not.   Confluent MAECs exposed to 24 hours OS, LS, or St were fixed with 4% 
paraformaldehyde and permeabilized before labeling with anti-cystatin C antibody 
(green) and anti-GM130 for cis-Golgi (red).  Co-localization is seen with the yellow.   
 
Since our hypothesis requires that cystatin C be secreted into the vessel wall to 
inhibit any cathepsins present there, it became important to identify the polarity of the 
secretion of this inhibitor.  Again, we used confocal microscopy to reconstruct a three-
dimensional picture of the endothelial cells and cystatin C.  Using vinculin, a focal 
adhesion protein, as a marker for the basal cell surface, MAEC were immunolabeled with 
anti-cystatin C (Figure 7.3A) and anti-vinculin (Figure 7.3B) antibody and after exposure 
to 24 hours of OS, LS, or St culture.  Hoechst was used to label cell nuclei.  Then, a 
three-dimensional projection was constructed from the Z-series of slices above and below 
the endothelial cell height.  From these images, it can be seen cystatin C (red) is co-
localizing in that basal region of the cell with the vinculin (green) suggesting its targeting 
out of the basal side into the basement membrane and that the nuclei sit above the 
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cystatin C (Figure 7.3D).  One can conjecture that if these cells were lining the arterial 
wall in vivo, then the protein would be secreted into the artery and not completely out of 
the luminal side.   
 
 
Figure 7.3.  Endothelial cells show packaging and basal secretion of cystatin C due 
to LS.  Immunostaining for cystatin C (A, red) and vinculin (B, green), a marker for focal 
adhesions.  Here we see that cystatin C is colocalizing with the basal cell marker (C).  
Projection (D) of sheared endothelial cells shows blue Hoechst stained nucleus above the 
cystatin C (Green here) additionally supporting its basal location. 
 
LS conditioned MAEC uptake more cystatin C from the extracellular environment. 
To block shear stress mediated, cathepsin dependent elastase activity, 0.5 µg/ml 
cystatin C was added to MAEC after exposure to shear with BODIPY-elastin.  Native 
cystatin C did not decrease elastase activity but increased it by 40%, 25%, and 28% in the 
LS, OS, and St cases, respectively over the boiled cystatin C samples (Figure 7.4A). 
It was also interesting to note that when MAECs were incubated with excess 
cystatin C in the presence of soluble elastin, it was detectable in the cell lysate by 
Western blots suggesting a mechanism by which cystatin C is endocytosed from the 
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media, or the blood.  There was a preferential uptake of cystatin C by those cells exposed 
to LS, and not because there was more cystatin C present since fresh media containing 
equal amounts of the protein was added to each (Figure 7.4A).  There was no preferential 
uptake of cystatin C when it was denatured by boiling, but an equal, general uptake under 
OS, St, and LS exposed MAEC (Figure 7.4B).  Those not incubated with the boiled 
cystatin C still did not have detectable levels in their cell lysates (Figure 7.4C).  Taken 
together, these results suggest that there is a mechanism by which cystatin C is 
selectively endocytosed by endothelial cells under high laminar shear stress conditions 
and may be able to transcytose it into the vessel wall whether they synthesized it 





Figure 7.4.  LS conditioned MAECs uptake more cystatin C than St or OS 
conditioned MAECs.    Confluent MAECs, after exposure to 24 hours of OS, LS, or St 
were incubated with either native or boiled 0.5 µg/ml cystatin C in the presence of 
BODIPY labeled soluble elastin.  Elastase activity is shown in (A) and W. blots of cell 
lysates are shown after incubation with native cystatin C (B) or denatured cystatin C (C). 
 
 
Endothelial cells overlying atherosclerotic regions reduce cystatin C production.   
To determine if cystatin C was important in vivo in the development of 
atherosclerosis, we performed immunohistochemical staining of human coronary arteries 





endothelial cell staining of cystatin C.  It was previously reported by Shi et al that 
cystatin C levels are decreased in atherosclerotic vessels and our findings corroborate 
that.  Additionally, it can be seen that the endothelium of the diseased vessel is not 
expressing cystatin C protein at all while the minimally diseased vessel stains strongly in 
the endothelial cell layer (Figure 7.5A, B).  Staining with von Willebrand factor shows 
the presence of endothelium in both vessels.  (Figure 7.5C, D) 
 
Figure 7.5.  Cystatin C immunohistochemistry.  Frozen sections of minimally diseased 
or atheromatous human coronary artery samples from patients receiving heart transplants 
were stained with anti-cystatin C antibody (A, B) or anti-von Willebrand factor (C, D). 
 
 
Binding cystatin C increases cathepsin activity. 
It still remained to be shown that cystatin C was inhibiting cathepsin activity 
extracellularly in response to LS. To do this, we used carboxymethylated papain as a sort 




which the name papain family of cysteine proteases was given to the cathepsins) but 
when papain is carboxymethylated, it loses its proteolytic activity but not its affinity for 
cystatin C.  Agarose beads coated with carboxymethylated papain (CM-papain) were 
sheared with MAEC under OS, LS, and St conditions and the conditioned media was 
collected to be used for Western blot and cathepsin activity assays.  As seen in figure 
7.6A, MAEC still elongate and align in the direction of flow with the beads present and 
are not scraped off of the plate.  Western blotting of the conditioned media confirms that 
the CM-papain does indeed bind the free cystatin C secreted by the endothelial cells 
(Figure 7.6B) during the shear stress exposure but does not bind cathepsin K, a prime 
target for cystatin C (Figure 7.6C).  
The conditioned media was then centrifugally concentrated and equal aliquots of 
protein were used for cathepsin activity assay with the fluorogenic, synthetic substrate Z-
GPR-AMC.  Figure 7.6D shows that without the CM papain beads, OS increases 
cathepsin activity by almost two-fold of the static and LS groups.  When the free cystatin 
C is bound to the CM papain beads the cathepsin activity under LS increases significantly 
and suggests that the reduced level of cathepsins that are present in the conditioned media 
after culture under LS are usually inhibited by cystatin C; without its binding, they are 
capable of hydrolytic activity.  
Additionally, we used a cystatin C plasmid to overexpress this protein in MAEC 
as seen in the conditioned media Western blots of figure 7.7.  Under OS, overexpressing 
cystatin C reduced Z-GPR-AMC hydrolysis to equal levels with the St and LS groups, 






Figure 7.6.  CM-papain beads bind cystatin C and increase cathepsin activity.  
Confluent MAECs were exposed to 24 hours of OS, LS, or St either with or without (9 
ng/ml) of carboxymethylated (CM) papain bound to agarose beads in serum free media 
and the conditioned media was collected and X protein was precipitated for W. blot or 
centrifugally concentrated for cathepsin activity assays (D).  Bar graph shows Z-GPR-
AMC hydrolysis as % of static control (n=3, * p<.05). 





Figure 7.7.  Overexpression of cystatin C reduces OS mediated cathepsin activity.  
MAEC transfected with cystatin C plasmid under constitutive CMV promoter were 
exposed to 24 hours OS, LS, and St conditions.  Conditioned media was collected for W. 
blot and cathepsin activity assay.  Bar graphs show Z-GPR-AMC hydrolysis as % of 
static control (n= 2 to 3). 
 
Discussion 
 Remodeling of the blood vessel wall is regulated by proteinases and their 
endogenous inhibitors.  Cystatin C, thhe most powerful endogenous inhibitor of the 
papain family of cysteine proteases, has been shown here to be regulated by shear stress 
in that 1) LS increases cystatin C mRNA and protein levels 2) LS causes cystatin C to be 
processed intracellularly through the Golgi apparatus for secretion while OS and St do 
not 3) Cystatin C seems to accumulate in the basal portion of the endothelial cell 4) 
Endothelial cells are capable of taking up cystatin C from the extracellular environment 
5) Endothelial cells overlying atherosclerosis do not express cystatin C, but those in the 
normal vessel do 5) binding free cystatin C increases cathepsin activity and 6) 
overexpressing cystatin C decreases cathepsin activity.  Together, these results indicate 
that cystatin C is atheroprotective in the vessel wall where it serves to inhibit cathepsin 
proteolytic activity. 
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 Cystatin C is a constitutively secreted protein by many different tissues with an 
intracellular half life of about 72 minutes (2), but here we are showing regulation of 
cystatin C protein levels by shear stress.  Promoter studies of cystatin C show that it has 
constitutive elements AND regulatory elements (11).  There are 11 Sp1 binding sites that 
may serve regulatory function (11) and Sp1 is known to be a shear responsive element 
that is phosphorylated due to LS (12-14).  Additionally, there is a GATA box in the 
promoter, and these are known to regulate endothelial cell expressed genes (11).  
Promoter analysis therefore supports the results that shear stress on endothelial cells 
regulates cystatin C transcriptional activity and is verified with our DNA microarray 
(Figure 7.1A).  The protein studies corroborate the microarray with increased cystatin C 
protein after LS exposure on endothelial cells (Figure 7.1B). 
 Cystatin C is elusive to detection intracellularly without cellular manipulation but 
we could label it fluorescently with antibodies in situ.  The finding that LS promotes 
proper packaging of cystatin C through the Golgi apparatus for secretion into the 
extracellular space (Figure 7.2) supports the increased protein level found in the 
conditioned media after LS exposure.  Normally, cystatin C forms an inactive dimer in 
the endoplasmic reticulum, is packaged for secretion in the Golgi, and is then secreted as 
a monomer (2).  Alterations to the cystatin C sequence can change this sequence of 
events.  The cystatin C gene without the leader sequence that targets it for secretion was 
transcribed and translated in retinal epithelial cells, was not secreted, and did not go 
through the Golgi apparatus (15).  In fact, immunostaining of the cells closely resemble 
the pictures presented here under OS and St conditions with diffuse cystatin C staining 
throughout the cell in comparison to sharp localization in the Golgi apparatus of the cells 
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exposed to LS or transfected with the cystatin C DNA containing the leader sequence.  
Since the cystatin C promoter has heterogeneous start sites and minor start sites (11), 
there may be alternative transcription under OS or St conditions that do not lead to the 
appropriate mRNA transcript with the leader sequence. 
Cystatin C localizing to the basal portion of the endothelial cell supports the 
findings of other groups that normal cystatin C is secreted basally (16).  
Immunohistochemistry of human coronary arteries for cystatin C showed a strong 
staining in the endothelium of the minimally diseased vessel, but a lack of endothelial 
cell staining in the vessel with the atherosclerotic plaque (Figure 7.5A, B).  It has been 
shown previously that atherosclerotic vessels do not contain cystatin C but normal, 
healthy vessels do (17).  Our staining serves to corroborate this evidence and to add the 
loss of cystatin C staining of the endothelium.  We are not sure whether these sections 
were at sites of disturbed flow in vivo before being removed for sectioning, but 
extrapolating from the accepted notion that atherosclerosis occurs at sites of disturbed 
flow, we can assume that the more diseased vessel was at a region of disturbed flow. This 
disturbed flow, or oscillatory shear stress, would have decreased endothelial cell 
production of cystatin C according to our in vitro results presented here. 
 Binding of free cystatin C serves to demonstrate its role in inhibiting cathepsin 
activity (Figure 7.6).  Immunoprecipitation would directly show this binding, but since 
our antibodies detect both the pro- and mature forms of the cathepsins, of which the 
proform was more abundant in the conditioned media, this assay could not be used.  The 
carboxymethylated papain beads serve to remove cystatin C from the system allowing the 
cathepsins to remain unbound and active leading to their increased activity extracellularly 
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under LS; the low levels of cathepsin present under LS still have activity when not 
inhibited by cystatin C (Figure 7.6D).  There was no increase by OS presumably because 
there was already a lowered level of cystatin C that was outnumbered by the increased 
cathepsin production stimulated by OS.  Overexpression of cystatin C in the endothelial 
cells reduced the OS mediated activity of the cathepsins, substantiating the idea that 
addition of cystatin C after OS, when levels are low, is sufficient to inhibit cathepsin 
activity (Figure 7.7). 
 In an attempt to use this concept to determine if extra cystatin C could inhibit the 
shear mediated and elastase activity that we have shown is cathepsin dependent, the 
results were confounding.  Addition of cystatin C did not reduce the elastase activity 
(Figure 7.4A).  Western blots on those cell lysates, for the first time, detected cystatin C 
intracellularly (Figure 7.4A), and preferentially for native, nondenatured cystatin C under 
LS (Figure 7.4B); boiled cystatin C was nonspecifically taken up under all shear 
conditions (Figure 7.4C).  This requirement for cystatin C to be in its native conformation 
suggests that there is some sort of receptor mediated uptake of cystatin C.  In vivo studies 
of cystatin C uptake by endothelial cells after intraretinal injection in mice has been 
previously studied advocating the idea that endothelial cells are capable of taking up this 
inhibitor (18).  It was further shown that this uptake in the retina is an active process that 
requires energy since lowering the temperature or depolymerizing actin with cytochalasin 
D reduced the uptake (19).  Again, this suggests a receptor mediated process.  Cystatin C 
receptors have not been identified, but there is evidence that it binds to the TGF-β R-II to 
antagonize its TGF-β signaling (20, 21); there are no reports yet of it being endocytosed 
by this receptor.  Cystatin C circulates in the plasma and it may be that endothelial cells, 
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aside from producing cystatin C under LS conditions, may also transcytose cystatin C 
from the plasma and pass it into the vascular wall to increase the concentration there for 
prevention of vascular remodeling due to cathepsins. 
 Understanding the atheroprotective mechanisms by which laminar shear stress 
maintains the integrity of the arterial wall and the elastic structures contained therein can 
prevent plaque formation.  These results show that cystatin C, the powerful inhibitor of 
the papain family of cysteine proteases that are being implicated in atherosclerosis, is 
important and that its inverse regulation with cathepsins maintains balance in this system; 
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CATHEPSINS, SHEAR STRESS, AND PROGRAMMED CELL 




During the course of studying the role of cathepsin K in shear stress induced 
elastase and gelatinase activity using siRNA, we noticed a side effect of vacuole 
formation and unhealthy endothelial cells even under static conditions.  It is reported that 
low or oscillatory shear stress induces apoptosis in endothelial cells (1) and that oxidized 
low density lipoproteins, which are increased at sites of disturbed flow and in 
atherosclerotic lesions, also lead to apoptosis in endothelial cells (2). Endothelial cell 
apoptosis involves the same changes as other apoptotic cells including loss of cell to cell 
contact, loss of contact with the matrix, movement of cytochrome c to the cytoplasm 
from the mitochondria, activation of caspases, subsequent Bid cleavage, 
phosphatidylserine exposure on the external surface of the plasma membrane, a loss of 
the anti-coagulant properties that make endothelial cell lining of the blood vessel wall 
necessary, membrane blebbing, and condensation of chromatin (3).   
Caspases are the cysteine proteases that trigger and effect the apoptotic pathway 
in cells.  The initiator caspases -2, -8, -9, and -10 activate the effector caspases -3, -6, and 
-7 that have cleavage targets throughout the cell and in the nucleus to cause the chromatin 
condensation and membrane blebbing that signal macrophage ingestion of the apoptotic 
cell in vivo and prevent any inflammatory response (4).   Cathepsin mediated mechanisms 
of apoptosis have also been shown to cross paths with the caspases; cathepsin L may also 
activate caspase-3 (5), and cathepsins B and L were found near TUNEL positive cells in 
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atherosclerotic lesions and with macrophages that were positive for caspase 3 (6).  
Additionally, translocation of cathepsins B and D from the lysosome to the cytoplasm is 
an initiating step in some types of apoptosis and in other forms of programmed cell death 
(7, 8). 
Here we investigated the mechanisms by which transfection of a sequence of 
siRNA, designed for cathepsin K, but additionally knocks down cathepsins B and L leads 
to endothelial morphology changes similar to apoptosis or programmed cell death.  We 
also show here that inhibition with a cathepsin K inhibitor induces these similar changes 
of membrane blebbing and vacuolar formation in mouse aortic endothelial cells and that 
these changes induce but are not dependent upon caspase activity.  
 
Methods 
Mouse Aortic Endothelial cells (MAEC) culture and shear stress studies.  MAEC 
obtained from the thoracic aortas of C57/BL6 mice were isolated, cultured in growth 
medium [Dulbecco’s modified Eagle’s medium (DMEM) containing 20% fetal bovine 
serum (FBS), 100 µg/ml endothelial cell growth supplement (ECGS, Sigma) and 2.5 
U/ml heparin] as described(9), and used between passages 7-10. Confluent endothelial 
monolayers grown in 100-mm tissue culture dishes were exposed to an arterial level of 
uni-directional LS (15 dyn/cm2) or OS with directional changes of flow at 1 Hz cycle (± 5 
dyn/cm2) for 1 day by rotating a Teflon cone (0.5° cone angle) as described 
previously(9). One hour prior to shear, the monolayers were washed and changed to 10 
ml of fresh shear medium (the growth medium without serum). 
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Transfection of siRNA.  To knockdown mouse cathepsin K mRNAs, the annealed 
siRNA duplex [sense: 5’- AAG GAU ACG UUA CUC CAG UCA tt’, antisense: 5’- 
UGA CUG GAG UAA CGU ACU CC tt] and nonsilencing duplex [sense: 5’- UUC UCC 
GAA CGU GUC ACG Utt, antisense: 5’- ACG UGA CAC GUU CGG AGA Att] were 
purchased from Qiagen. Subconfluent (75-80% confluency) MAEC were transfected at a 
final siRNA duplex concentration of 100 nM using Oligofectamine (Invitrogen) in serum 
free medium.  After 6 hrs, the medium was supplemented with fetal bovine serum (final 
10% concentration) and cultured an additional 42 hrs prior to exposing the cells to either 
OS, LS, or no flow conditions. 
 
Elastase assay.  Five µg/ml of BODIPY® fluorescein-conjugated DQ™ elastin 
(Molecular Probes) in fresh serum-free DMEM was incubated with MAEC following 
exposure to OS, LS, or St for one day or in six well plates under static conditions in the 
absence or presence of 50 µM E64 (Sigma), 50 µM GM6001 (Calbiochem), 50 µM of the 
cathepsin K inhibitor, 1,3-Bis(CBZ-Leu-NH)-2-propanone, (Calbiochem), or the vehicle.  
After an additional 24 hours, aliquots (200 µl) of conditioned media were assayed with a 
fluorescence plate reader, in triplicate, with background fluorescence subtracted from the 
no-cell negative control at 485 nm excitation and 525 nm emission. 
 
Annexin V-FITC Apoptosis detection.   Kit was used according to manufacturer 
instructions.  Briefly, 48 hours after transfection with nonsiRNA or cathepsin K370 
siRNA, cells were trypsinized and resuspended in media.  Media binding reagent was 
added to 500 µl of cell suspension followed by 1.25 µl Annexin V-FITC ad incubated in 
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the dark for 15 minutes.  Cells were pelleted at 100 x g for 5 minutes ad resuspended in 
1X binding buffer.  Propidium iodide was then added to the samples.  Samples were 
analyzed by flow cytometry detecting FITC on FL1 detector at 518 nm and detection of 
propidium iodide on FL2 at 620 nm. 
 
Caspase 3/7 activity assay.  Apo3 HTS Apoptosis kit (Cell Technology) was used 
according to manufacturer instructions.  Briefly, after shear or culture in 6 well plates, 
cells were scraped in PBS and lysed with the proprietary lysis buffer supplemented with 
15 mM fresh DTT and the caspase reagent, quenched bisubstituted Z-DEVD R110 Dye 
reagent.  After cleavage by caspases, the R110 Dye is free and fluorescence is read with a 
spectrofluorometer excitation 488 nm and emission 525 nm in a 96 well plate and 
normalized to total protein. 
 
Cathepsin activity assay.  Cells were lysed in 40 mM sodium acetate buffer, pH 5.5, 
.1% Triton-X 100, and conditioned media were collected and concentrated.  Aliquots 
were added to a reaction mixture containing 100 mM acetate, pH 5.5, 2.5 mM EDTA, 2 
mM dithiothreitol, and 0.1% Brij 35.  Benzyloxycarbonyl-Gly-Pro-Arg-7-amino-4-
methylcoumarin (Z-GPR-AMC) (Biomol) was used as the substrate and added to attain a 
final concentration of 25 µM after the cathepsins were activated for two minutes at 37°C 
(10).  The reaction mixture was incubated at 37°C for 60 minutes, and AMC fluorescence 
intensity was determined with a fluorescence plate reader (excitation at 360 nm and 
emission at 460 nm). 
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Western blots. Following shear, cells were lysed with RIPA buffer and conditioned 
media concentrated as above.  Equal amounts of total protein were resolved by SDS-
PAGE, and the blots were probed with antibodies to cathepsins L (1:500, R&D), K 
(1:200, Calbiochem), B (1:250, Calbiochem), or β-actin (1:1000, Santa Cruz) and 
appropriate secondary antibodies conjugated to alkaline phosphatase, which were 




Knocking down cathepsin K in endothelial cells affects cell health. 
We used a sequence of siRNA to knockdown cathepsin K in MAEC to investigate 
the contribution of cathepsin K to endothelial cell elastase and gelatinase activity.  
MAEC were transfected with a sequence denoted as Cath K370 or a non-silencing RNA 
control 48 hours prior to exposure to 24 hours of St, OS, or LS conditions in serum free 
media.  Cath K370 is different from the specific siRNA sequence used in Chapter 5 
(Table 8.1). 
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Table 8.1 Different targets of cath K370 siRNA sequence and the other cath K 
siRNA sequence from chapter 5. 
 
 
Pictures of the cells were captured with a digital camera after shear, and as expected 
MAEC exposed to LS elongated and aligned in the direction of flow.  There were 
differences in the cells themselves, however.  Those MAEC transfected with Cath K370 
showed vacuole formation and membrane blebbing, particularly in the St and OS 
conditions while those transfected with the nonsiRNA did not show such formations 
suggesting that it was not due to the transfection (Figure 8.1).  In another assay, we used 
the pharmacological inhibitor of cathepsin K (1,3-Bis(CBZ-Leu-NH)-2-propanone), and 
with increasing concentrations of the cathepsin K inhibitor I, there was increased 
endothelial cell death (Figure 8.2A).  Elastase activity was inhibited by the K inhibitor, 
E64, and N-Methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (MK), the serine 
protease inhibitor (Figure 8.2B).  Taken together with the siRNA results, these results 
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Figure 8.1.  Transfection with cathepsin K 370 siRNA induces MAEC cell blebbing 
and vacuole formation.  MAEC were transfected with Cath K370 siRNA or a non-
silencing RNA control 48 hours prior to exposure to 24 hours of OS, LS, or St conditions.  











































Figure 8.2.  Cathepsin K inhibition with pharmacological inhibitor also induces 
MAEC morphology changes and cell death.  Digital micrographs of cell morphology 
were also captured (A) after static MAEC were cultured with soluble BODIPY-elastin in 
the presence of various inhibitors and increasing concentrations of the cathepsin K 





Cathepsin K 370 siRNA also knocks down cathepsins B and L. 
 
 
Figure 8.3.  Cath K370 siRNA knocks down cathepsins B, K, and L.  MAECs were 
transfected with Cath K370 siRNA 48 hours prior to 24 hours of OS, LS, and St 




Since we could rule out siRNA transfection as the cause of the endothelial cell 
morpohological changes with the nonsiRNA result, we wanted to be sure that the loss of 
cathepsin K was the cause.  To check the specificity of the siRNA, Western blots for 
cathepsins B, L, and S were performed on the cell lysates of MAEC transfected with Cath 
K370.  Although the Cath K370 sequence BLAST did not reveal sequence homology to 
cathepsins B, L, or S, it was seen that the transfection cross reacted and knocked down 
the protein levels of cathepsins B and L as well as K under all shear conditions (Figure 
8.3).  Cathepsins B and L have been linked to programmed cell death in other cell types 
which could account for the morphological changes seen in the MAEC transfected with 
Cath K370.  It not only knocked down protein levels of the cathepsins, but also 
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significantly reduced their activity in the conditioned media as seen with the cathepsin 
substrate Z-GPR-AMC that is susceptible to cleavage by cathepsins B and K.  
Conditioned media from MAEC exposed to 24 hours of OS, LS, or St conditions was 
assayed for Z-GPR-AMC hydrolysis.  OS significantly increased cathepsin B and K 
activity in the conditioned media by 200% over St and LS, and knockdown with Cath 
K370 blunted this (Figure 8.4A). 
 Cathepsins K and L are known to be strong elastases, and our previous data 
verified their involvement in shear mediated elastase activity of MAEC, so we 
investigated how transfection with Cath K370, and knocking down both elastinolytic 
cathepsins, would affect cell mediated elastase activity.  From figure 8.4B, it is clear that 
cathepsins K and L contribute to about 40% of the total elastase activity of MAEC.  
MAEC exposed to OS showed approximately two-fold higher elastase activity than that 
of LS, which was substantially inhibited by two different concentrations of cathepsin K 
inhibitor I (0.2 and 50 µM) (Figures 8.4 C and D).  The lower concentration, 0.2 µM is 
close to the IC50 for this cathepsin K inhibitor with cathepsin K.  It was interesting to note 
that the elastase activity between OS and static exposed cells were not different from 
each other (Figure 8.4B-D), even though the cathepsin K activity was significantly higher 
in OS-exposed cells than the static cells (Figure 8.4A).  Western blots on the conditioned 
media showed that incubation with the cathepsin K inhibitor led to increased secretion of 
mature cathepsin K although the activity was blocked (Figure 8.5B).  There was also 
decreased secretion of cystatin C after incubation with the cathepsin K inhibitor 
suggesting that there is a cathepsin K mediated function that the MAECs are trying to 




Figure 8.4.  Cathepsin K 370 siRNA significantly reduces cathepsins B and K 
activity.  After shear exposure, conditioned media was assayed for Z-GPR-AMC 
hydrolysis (A) and elastase activity (B).  Bar graphs represent average values normalized 
to Static control of at least 3 independent experiments (* p<.05).  Following 1 day 
exposure of MAEC to OS, LS, or static conditions, the cells were further incubated 
overnight under no flow conditions in fresh media containing BODIPY-elastin in the 
absence or presence of cathepsin K Inhibitor I at 0.2 µM (Panel C) and 50 µM (Panel D). 
Elastase activity, measured as an increase in fluorescence intensity, was shown as % of 




Figure 8.5.  Addition of cathepsin K inhibitor increases mature cathepsin K levels 
extracellularly but decreases extracellular cystatin C.  Western blots of conditioned 
media after incubation with BODIPY-elastin and 50 µM Cath K inhibitor I probing for 
cathepsin K (A) and cystatin C (B). 
 
From the micrographs of the MAEC after transfection with Cath K370, it 
appeared that the cells were undergoing apoptosis so we employed apoptosis assays to 
quantify this.  MAEC were transfected with either nonsilencing RNA or Cath K370 for 
48 hours prior to labeling with FITC labeled Annexin V to bind phosphatidylserine that 
had been flipped to the outer cell membrane, a marker of apoptosis.  Cells were also 
labeled with propidium iodide to label dead cells or cells undergoing necrosis.  After 
FACS analysis, there was no increase in the FITC positive, propidium iodide negative 






Figure 8.6.  Cathepsin K siRNA induced cell death is not apoptotic. 
 
To investigate caspase activity, we used the ApoHTS system from Cell 
Technology using a quenched caspase susceptible peptide.  MAEC were transfected with 
either nonsiRNA or Cath K370 prior to shear after which, cells were scraped in PBS and 
lysed with the proprietary ApoHTS lysis buffer, and then incubated with the fluorescent 
substrate cleaved by caspases 3 and 7.  From figure 8.7, nonsiRNA transfected groups 
had the same level of caspase 3/7 activity regardless of the types of shear stress to which 
they were exposed.  On the other hand, transfection with Cath K370 siRNA increased 
caspase 3/7 activity by 50% in the St and OS cultured MAEC suggesting that since LS 
downregulates cathepsin activity, knocking it down further does not induce cell death (or 
at least does not induce caspase 3/7); cathepsin activity and expression under regions of 
stagnant or oscillatory flow may be necessary for cell function, of which that function is 
not currently known.  Additionally, increasing concentrations of cathepsin K370 siRNA 





Figure 8.7.  Cathepsin K 370 siRNA increases apoptosis in MAEC under static and 
OS, but not LS.  MAEC were transfected with either Cath K370 or a nonsiRNA, sheared 










Knocking down the combination of cathepsins B, K, and L induced programmed 
cell death in a caspase 3/7 independent manner. 
We next tested the hypothesis that blocking caspase activity in the MAEC after 
transfection with Cath K370 could block the cell morphology changes indicative of 
programmed cell death.  To do this, we transfected the cells with either the nonsiRNA or 
Cath K370 and then incubated them with Z-VAD-FMK, an inhibitor of caspase-1, -3, -4, 
and -7, Z-IETD-FMK, a caspase 8 inhibitor, or Z-LEHD-FMK, a caspase 9 inhibitor.   
Caspase 8 and 9 are upstream of caspase 3 and 7.  Micrographs of the cells still showed 
the cell morphology changes in the MAEC transfected with Cath K370 indicating that 
programmed cell death occurs even in the presence of the caspase inhibitors.  This 






Figure 8.9. Knocking down cathepsins B, K, and L induced programmed cell death 
in a caspase 3/7 independent manner.  MAECs transfected with Cath K370 siRNA 
were cultured under static conditions in the presence of the caspase inhibitors Z-VAD-
FMK, a pan caspase inhibitor, Z-IETD-FMK, a caspase 8 inhibitor, or Z-LEHD-FMK, a 
caspase 9 inhibitor.  Light micrographs (A) of the cells before lysis and Caspase 3/7 
activity assay (B).  
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 Transfected cells were stained for cathepsin K, cis-Golgi, and transferring 
receptor.  Cathepsin K staining verified knockdown of cathepsin K with this sequence of 
siRNA as seen with the diminished fluorescent labeling when images were captured 
under the same confocal settings (Figure 8.10 A, B).  Cis-Golgi was fragmented in the 
cells transfected with K370 compared to intact Golgi on one side of the nucleus as seen in 
the nonsiRNA groups (Figure 8.10 C, D).  Transferrin receptors are markers for 
endosomes, and from the staining (Figure 8.10 E, F), the vacuolar structures induced by 
K370 transfection were not endosomal in nature as they do not stain positive.  We further 
added bafilomycin A1 to block the V-ATPase proton pump that would shrink the 
vacuoles if they were acidic.  Two concentrations were used (10 µM and 100 µM) but 






















Figure 8.10.  Cath K370 siRNA knocks down cathepsin K, transferrin receptor, and 
disrupts cis-Golgi apparatus.  MAEC transfected with nonsiRNA or Cath K370 were 
cultured under static conditions, had their cytoplasm extracted, were fixed, and 
immunostained for cathepsin K (A,B), GM130 for cis-Golgi (C,D), and transferrin 















Figure 8.11.  Bafilomycin A1 treatment does not shrink vacuoles induced by Cath 
K370.  MAEC transfected with 100 nM of either nonsiRNA (A, C, E) or Cath K370 (B, 




 The findings presented here show that 1) knockdown of cathepsins B, K, and L in 
endothelial cells with siRNA induces morphological changes indicative of a programmed 
cell death; 2) this programmed cell death increases caspase activity under static and OS 
conditions, but LS seems to protect the cells; 3) inhibition of caspases does not block the 
morphological changes of the MAEC; 4) a pharmacological inhibitor of cathepsin K that 
cross inhibits cathepsins L and S additionally induces this cell death, increases secretion 
of mature cathepsin K, and decreases cystatin C secretion. 
 OS increases apoptosis in endothelial cells (1, 12) and increases cathepsin activity 
(13).  Several reports of cathepsin involvement in apoptosis have been reviewed (3, 4, 14) 
especially implicating cathepsins B, D, and L in the process.  Here we see that blocking 
cathepsin activity either with siRNA or with pharmacological inhibition is 
counterintuitive by serving to increase cell death instead of preventing the completion of 
the apoptotic cascade.  It is important to recognize that there are other forms of 
programmed cell death besides apoptosis that lead to similar morphology changes in 
cells.  Caspase independent cell death and autophagy are other mechanisms by which 
cells commit to death in cascades that do not induce inflammation.   
 Autophagy is characterized by large vacuole formation, as seen in our endothelial 
cells after transfection with Cath K370 siRNA, caspase activation late in the process, if at 
all, and activation of cathepsins and other proteases (14, 15).  The presence of large 
vacuoles does not mean that a cell is autophagic, particularly in this condition.  
Cathepsins are lysosomal proteases that function in the lysosome to turn over protein; 
cathepsin K knockout macrophages actually have enlarged lysosomes due to a loss of this 
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proteolytic activity (16).  Other markers of autophagy such as LC3 fragmentation and 
Monodansylcadaverine uptake by autophagic vacuoles should be used to confirm 
autophagic induction in our system (15, 17).  To compound the situation, it is important 
to note that cells undergoing autophagy do not necessarily die.  It is a process used to 
reduce the cell volume and may be anti-apoptotic in that it sequesters small mitochondria 
that are usually used to trigger the intrinsic apoptotic pathway (15).  
 Caspase independent cell death pathways elicit some of the changes seen in 
apoptosis, but may not complete the entire cascade.  Lockshin and Zakeri caution against 
assuming that the presence of caspases means that the cell death depends on caspase 
activity and that blocking caspases with inhibitors will not keep the cell alive (18).  A cell 
committed to death will undergo a different pathway to get there and find a way to die.  
Lysosomal proteases that are leaked into the cytoplasm or the nucleus may cause damage 
to the cell structures without dependence on caspase activity (18) and could be 
responsible for numerous cell death morphologies that blur the lines between necrosis, 
autophagy, and apoptosis (19).  Cathepsins may work upstream of the initiator and 
effector caspases as indicated by cathepsin activation of caspases (5), or downstream seen 
with caspase induced lysosomal membrane permeabilization to release cathepsins (20). 
 The finding here that knockdown of cathepsins B, K, and L induces a 
programmed cell death that is not dependent on caspase activity but does affect caspase 
activity based upon the shear stress condition on the mouse aortic endothelial cells, 
suggest the involvement of cathepsins at different stages of the cell death pathway.  
Laminar shear stress, known to be anti-apoptotic through nitric oxide production (21, 22) 
and other mechanisms protect the endothelium from traversing down a path to cell death.  
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Elucidating the specific death pathway in response to cathepsin knockdown could be 
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In total, this body of work presents data implicating cathepsins, the papain family 
of cysteine proteases in cardiovascular disease, and more particularly, with shear stress 
mediated endothelial cell responses including vascular remodeling, cell alignment, and 
programmed cell death.  Of the numerous enzymes that comprise this family, focus has 
been placed on cathepsins B, K, L, and S; cathepsin K, L, and S being highly elastinolytic 
and collagenolytic, and cathepsin B being overly abundant in the cells.  Cystatin C also 
serves to regulate cathepsins in the cardiovascular system as shown by its shear 
regulation inversely to the cathepsins suggesting a balancing act tipping the scale towards 
inhibition of proteases under unidirectional laminar shear stress but switching to a 
proteolytic environment under oscillatory shear stress by downregulating the inhibitor.   
The in vitro endothelial work presented here offers mechanisms to the finding that 
atherosclerosis occurs at sites of the vascular tree that are exposed to disturbed flow 
conditions where the endothelium is exposed to oscillatory shear stress such as at 
bifurcations and sharp turns.  Proteolytic remodeling of the vessel wall occurs at these 
sites and that is where our cathepsin balance in the endothelium switches from inhibitory 
to proteolytic.  In contrast, straight regions of the arterial tree exposed to high 
unidirectional laminar shear stress are protected from plaque formation, and the 
endothelial cells suppress cathepsin expression and activity and highly secrete their 
endogenous inhibitor, cystatin C.  This balancing act not only holds relevance for 
atherosclerosis, but also for abdominal aortic aneurysms which are also under low and 
oscillatory flow, and for heart valve diseases that occur on the aortic side of the leaflet 
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where there is turbulent and disturbed flow when the leaflets close or when stenoses and 
other physiological complications cause jet streams, flow eddies, and flow reversal. 
 To better address key targets for intervention strategies, the underlying 
mechanisms must be elucidated.  Then, the most susceptible target or pathway can be 
identified to inhibit the pathological remodeling and retard plaque and aneurismal 
formation.  Shear stress activates kinase signaling pathways in the cell that lead to gene 
expression.  MAP kinases including ERK 1/2, JNK, and p38 lead to eNOS, Akt, and 
ultimately to endothelial cell functions (1, 2).  Additionally, these kinases activate 
transcription factors NF-KB, SMAD, AP-1, c-Jun, c-fos, and c-myc to bind to their 
targets and turn on gene expression, of which ICAM-1 and MMP-9 are examples (3-7).  
Cathepsins may be the downstream result of these pathways.  Already, ERK has been 
linked with cathepsin L overexpression in tumor cells.  NIH 3T3 fibroblasts used 
cathepsin L for metastasis after activation of ERK and suppression of JNK; this was all 
downstream of ras activation and the pathway Ras to Raf to MAPKK to ERK activation 
(8, 9). 
 Promoter analysis of cathepsins K and L reveal AP-1 binding sites; (10, 11).  This 
is a shear stress responsive transcription factor (12) that could be working to positively or 
negatively affect cathepsin gene transcription in endothelial cells.  Cathepsin L and 
cathepsin B have promoters  that contain Sp-1 binding sites (13, 14) which is another 
known shear stress responsive transcription factor (15).  Methylation of the cathepsin L 
promoter decreases its activity (14).  Studies of whether these shear responsive elements 
activate or inhibit cathepsin gene transcription will help explain the changes in their 
protein level under OS and LS. 
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 Regulation of cathepsin activity occurs at several levels from transcription to 
translation, but also including cleavage of the propeptide to the mature, active cathepsin, 
and targeting either to the lysosome or for secretion.  Once outside of the cell, the 
cathepsin is not in an environment optimal for its catalytic activity so outside influences 
must create a slightly acidic environment to turn on cathepsin function, although some 
studies find cathepsin activity under neutral pH (16, 17).  Cathepsin secretion is not fully 
understood, especially since there is no signal sequence to target them for secretion, but it 
has been suggested that the carboxyterminus of procathepsin L has such a sequence (18).  
Secretory lysosomes (19) and alternative targeting pathways suggest that overexpression 
of cathepsins B and L overloads the lysosomal targeting (the traditional mannose-6-
phosphate receptor mediated path) and causes them to be secreted instead (17, 20).  
Procathepsin L aggregation into multivesicular bodies occurs when it is overexpressed 
and may lead to mannose-6-phosphate receptor independent secretion (21).  Cathepsin K 
is known to be secreted at the ruffled border in osteoclasts by still unidentified 
mechanisms (22, 23).  Improved knowledge of these mechanisms may expose a target for 
intervention so that in cases of overexpression, such as oscillatory shear stress, the 
cathepsins will still not be secreted into the extracellular space where they cause disease. 
 Cytokines also induce overexpression and secretion of cathepsins.  This has been 
shown to be true for macrophages, smooth muscle cells, and endothelial cells.  IFN 
gamma increases cathepsin L mRNA in all three of the cell types while TNF alpha 
increases cathepsin L mRNA in SMC and EC but not in macrophages (24).  Cystatin C 
secretion by SMCs is increased with TGF-B although there is no change in the mRNA 
levels (25).  It also interferes with the TGFBRII to antagonize its binding of TGF-B in 
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tumor cells (26, 27).  If the same binding occurs for SMCs, then this may be a possible 
negative feedback mechanism to shut down the TGF-beta mediated secretion of cystatin 
C. 
 After secretion, cathepsins must be activated.  Macrophages, upon coming into 
contact with elastin, create tight microenvironments into which they pump protons by a 
vacuolar type ATPase to acidify it (28).  Here, cathepsin activity is enhanced.  
Atherosclerotic plaque environments’ pH is slightly acidic (29) and this could partially be 
due to macrophage infiltration and the inflammatory process.  Cathepsins are capable of 
autocatalytically cleaving their propeptide under acidic conditions (30-32), but are also 
capable of cleaving the propeptide off of each other eliciting a positive feedback of more 
active cathepsins (30, 33) to exacerbate the proteolysis and tilt the balance.  Under a 
disturbed flow environment with reduced cystatin C, there would be no inhibitor present 
to suppress their activity. Glycosaminoglycans (GAGs) complex with cathepsins to 
modify their activity towards different ECM substrates.  In particular, chondroitin sulfate 
complexes with cathepsin K to increase its collagenolytic activity but suppresses its 
elastase activity (34, 35).  This may be involved with our finding that cathepsin K siRNA 
shows greater reduction in gelatinase activity than elastase activity.  GAG production by 
shear stress is not known.  Endothelial cell glycocalyx GAGs in conjunction with acidic 
microenvironments may play a part in activation or deactivation of cathepsins in the local 
environment and their proteolytic potential. 
 Ultimately, in vivo animal studies to link flow with cathepsin activity must be 
done to validate these in vitro findings.  Already, cathepsins K and S knockout mice 
crossed with the atherosclerotic model of ApoE-/- and LDLR-/- mice fed high fat diets 
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have produced results that implicate cathepsins in matrix remodeling and atherosclerotic 
plaque development (36, 37).  Knockout of cystatin C in those models further supports its 
inhibitory role in the process as a greater number of breaks in the elastica layers and 
aortic dilation were seen (38, 39).  The plaques in these animals occur at 
hemodynamically defined regions of disturbed flow, such as the aortic arch, but more 
definitive studies should be done to link cathepsins and disturbed flow in vivo.  Altering 
flow by partially ligating the left coronary artery to cause low flow there but high flow in 
the right coronary artery (40) in conjunction with immunohistochemistry and cathepsin 
zymography can clearly test the hypothesis that high flow and unidirectional shear stress 
inhibit cathepsin activity and prevent pathological vascular remodeling.  Arteriovenous 
fistula models have been done in mice and rabbits as well to generate high flows and to 
investigate proteolytic activity (41, 42).  MMP-2 and -9 have been increased in these 
models compared to low flow, but this has also been verified at the endothelial cell level 
in vitro (43) where shear stress increases their activity over static conditions.   
 Cathepsins are “breaking out” of the lysosomes from where they were initially 
discovered and are not only causing disease states, but also are opening investigations 
into the mechanisms of different disease developments and pathological remodeling for 
which they were originally ignored.  This work illustrates the shear stress mediated 
regulation of cathepsin activity in endothelial cells from mouse aortas but also has 
implications towards several cardiovascular pathologies which are leading killers in the 
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